Other peripheral vertigo

H8_PERIPHVERTIGO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H81.3 Cause of death: ICD-10 — H81.3 2 out of 7 registries used, show all original rules.	4245
4. Check minimum number of events None	4245
5. Include endpoints None	4245
6. Filter based on genotype QC (FinnGen only)	3837

Control definitions (FinnGen only)

Control exclude: H8_INNER

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H81
Name in latin: Alia vertigo peripherica

NAME	H8_PERIPHVERTIGO
CONTROL_EXCLUDE	H8_INNER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H813
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H813
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other peripheral vertigo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	22431	14326	8009
Only index persons	21331	13746	7585
Unadjusted period prevalence (%)
Whole population	0.34	0.41	0.22
Only index persons	0.43	0.51	0.29
Median age at first event (years)
Whole population	59.92	60.67	58.74
Only index persons	59.30	59.97	58.08

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3837	2508	1329
Unadjusted period prevalence (%)	0.79	0.89	0.61
Median age at first event (years)	59.40	58.22	61.65

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3959: Matched controls
39590

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H81.2

ICD-10 Finland

Vestibular neuronitis

224.2

307.7

421

DFF59

NOMESCO Finland

Other assessment of balance

35.4

307.7

262

N07CA01

ATC

betahistine; oral

11.7

307.7

1097

1251

H81.0

ICD-10 Finland

Ménière disease

95.5

307.7

494

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

12.0

307.7

1172

1345

R42

ICD-10 Finland

Dizziness and giddiness

11.0

307.7

2614

5949

H81.3

ICD-10 Finland

Other peripheral vertigo

4503599627370496.0

307.7

3957

158

N17

ICPC

Vertigo/dizziness

3.7

249.8

985

3241

DFF00

NOMESCO Finland

Pure tone audiometry

3.9

224.2

786

2374

Z01.1

ICD-10 Finland

Examination of ears and hearing

3.4

222.6

991

3501

DFF50

NOMESCO Finland

Electronystagmography

84.6

202.2

107

AA1AD

NOMESCO Finland

CT of head and brain

2.7

201.3

1700

8514

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

5.9

187.6

359

662

H81.4

ICD-10 Finland

Vertigo of central origin

26.4

170.8

118

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

18.1

170.3

138

DFF40

NOMESCO Finland

Otoneurologic examination of vertigo

33.9

150.7

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

9.5

125.4

150

163

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

2.3

96.8

946

4781

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

5.1

93.4

200

405

UDC00

NOMESCO Finland

Ear microscopy

3.1

93.0

430

1503

R51.80

ICD-10 Finland

Headache

2.4

91.6

783

3727

G44.2

ICD-10 Finland

Tension-type headache

2.4

89.9

708

3246

H82

ICPC

Vertiginous syndrome

5.9

87.7

161

283

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

87.4

1633

10444

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.7

85.1

510

2048

DC1AD

NOMESCO Finland

Temporalbone CT

8.9

84.6

106

122

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

82.2

1352

8240

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

7.8

77.7

109

144

R11

ICD-10 Finland

Nausea and vomiting

2.6

74.7

480

1989

H93.1

ICD-10 Finland

Tinnitus

2.7

65.8

372

1443

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.5

63.6

460

2010

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

63.3

430

1825

N05AB04

ATC

prochlorperazine; systemic, rectal

4.6

62.9

153

344

L01

ICPC

Neck symptom/complaint

2.0

59.8

766

4209

A02BC02

ATC

pantoprazole; systemic

1.8

59.0

2873

23466

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

58.7

2067

15407

R07.3

ICD-10 Finland

Other chest pain

2.2

55.4

520

2534

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

54.5

984

6037

M54.5

ICD-10 Finland

Low back pain

1.7

53.9

1535

10725

M79.6

ICD-10 Finland

Pain in limb

1.7

53.7

1861

13694

R53

ICD-10 Finland

Malaise and fatigue

1.8

52.9

1102

7048

M03BX02

ATC

tizanidine; oral

1.7

52.6

2441

19334

A02BC05

ATC

esomeprazole; systemic

1.7

51.7

1710

12389

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.3

51.2

403

1822

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

51.0

814

4791

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

47.6

985

6257

H02AB06

ATC

prednisolone; systemic

1.6

47.4

1962

14928

R06.0

ICD-10 Finland

Dyspnoea

1.7

46.8

1202

8097

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

46.6

1263

8630

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

44.1

963

6191

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

43.7

775

4689

H53.1

ICD-10 Finland

Subjective visual disturbances

2.3

43.6

347

1573

M54.2

ICD-10 Finland

Cervicalgia

2.2

42.9

378

1787

DFF15

NOMESCO Finland

Speech audiometry

2.6

42.4

260

1045

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

42.3

475

2466

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

42.0

594

3343

N02BE01

ATC

paracetamol; systemic, rectal

2.1

41.8

3596

32571

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

41.7

293

1256

R01AD09

ATC

mometasone; nasal

1.6

40.3

1743

13223

R01AD08

ATC

fluticasone; nasal

1.6

40.0

1119

7649

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

3.4

39.8

145

436

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.4

39.7

298

1316

K30

ICD-10 Finland

Functional dyspepsia

2.0

39.6

514

2807

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

39.3

1780

13618

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

39.1

773

4809

N01

ICPC

Headache

2.0

38.9

433

2239

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

2.4

38.7

274

1178

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

38.5

1225

8628

R55

ICD-10 Finland

Syncope and collapse

2.0

38.2

491

2671

PA6AD

NOMESCO Finland

CT of neck arteries

2.8

38.1

198

731

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

38.1

1136

7871

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

37.8

649

3872

H80.9

ICD-10 Finland

Otosclerosis, unspecified

134.7

37.8

R00.2

ICD-10 Finland

Palpitations

2.2

37.5

359

1753

N03AX16

ATC

[U] pregabalin

1.7

37.4

958

6385

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

36.7

863

5622

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

36.1

250

1063

G47.3

ICD-10 Finland

Sleep apnoea

1.7

36.0

886

5837

J01DB01

ATC

cefalexin; oral

1.7

35.8

3211

28389

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.4

35.7

253

1088

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

35.5

1043

7180

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

35.2

540

3107

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

35.1

369

1866

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

35.0

687

4254

L17

ICPC

Foot/toe symptom/complaint

1.6

34.2

1261

9134

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

34.2

985

6738

Z01.2

ICD-10 Finland

Dental examination

1.5

34.0

1751

13630

H02

ICPC

Hearing complaint

1.7

34.0

658

4056

H80.0

ICD-10 Finland

Otosclerosis involving oval window, nonobliterative

176.5

33.8

R12

ICD-10 Finland

Heartburn

2.0

33.2

367

1889

A11

ICPC

Chest pain NOS

2.0

33.1

395

2089

M79.1

ICD-10 Finland

Myalgia

1.8

33.0

612

3722

J01AA02

ATC

doxycycline; systemic

1.6

32.6

3058

26899

R03AC02

ATC

salbutamol; inhalant

1.5

32.4

2103

17095

M01AH05

ATC

etoricoxib; oral

1.5

32.3

2384

19883

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

32.3

692

4379

L03

ICPC

Low back symptom/complaint

1.6

32.3

1174

8458

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

32.0

1964

15771

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

31.7

457

2573

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

31.3

1700

13301

N06AX11

ATC

mirtazapine; oral

1.5

30.9

1348

10075

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

30.5

471

2708

R01AD58

ATC

fluticasone, combinations; nasal

1.6

30.5

905

6209

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

30.4

429

2398

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

30.3

611

3800

M01AB05

ATC

diclofenac; systemic, rectal

1.5

30.2

2508

21274

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

30.2

917

6323

UJF32

NOMESCO Finland

Coloscopy

1.5

30.1

1076

7698

J01FA10

ATC

azithromycin; systemic

1.5

30.1

2099

17202

S06.0

ICD-10 Finland

Concussion

1.9

30.0

430

2416

J01FA09

ATC

clarithromycin; systemic

1.5

29.9

1167

8509

M25.5

ICD-10 Finland

Pain in joint

1.5

29.6

1290

9622

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.9

29.3

434

2463

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

29.2

293

1453

A02BC03

ATC

lansoprazole; oral

1.5

29.1

1131

8227

J01MA02

ATC

ciprofloxacin; systemic

1.5

29.1

1491

11482

R51

ICD-10 Finland

Headache

2.3

29.0

230

1038

XF404

NOMESCO Finland

Ambulatory ECG

1.9

28.7

368

1991

N02AX02

ATC

tramadol; systemic, rectal

1.5

28.7

1661

13089

A02BA02

ATC

ranitidine; systemic

1.6

28.5

774

5189

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

4.5

28.5

155

M01AE02

ATC

naproxen; oral, rectal

1.5

28.3

2102

17343

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.8

28.3

146

537

H92.0

ICD-10 Finland

Otalgia

2.2

28.2

262

1262

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.4

28.0

195

831

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

28.0

762

5110

UKC02

NOMESCO Finland

Cystoscopy

1.7

27.9

624

3981

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

27.9

208

914

DAX08

NOMESCO Finland

Fitting of hearing aid

2.1

27.8

268

1309

DDA00

NOMESCO Finland

Stapedotomy

78.2

27.8

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

27.8

470

2776

R05

ICPC

Cough

1.5

27.7

991

7068

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

27.2

557

3469

H29

ICPC

Ear symptom/complaint other

1.7

26.7

509

3108

H02AB04

ATC

methylprednisolone; systemic

1.7

26.7

572

3607

C07AB07

ATC

bisoprolol; oral

1.4

26.6

1937

15851

R02

ICPC

Shortness of breath/dyspnoea

1.7

26.6

579

3666

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

26.4

1133

8385

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

26.3

1633

12968

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

25.9

417

2424

C07AA05

ATC

propranolol; systemic

1.6

25.8

747

5070

S18

ICPC

Laceration/cut

1.4

25.8

1852

15086

A04

ICPC

Weakness/tiredness general

1.6

25.7

648

4257

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

25.4

486

2968

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

25.4

1537

12127

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

25.4

334

1822

R05

ICD-10 Finland

Cough

1.5

25.2

856

6021

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

25.1

310

1654

H83.1

ICD-10 Finland

Labyrinthine fistula

+∞

25.0

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.6

25.0

144

561

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

2.0

24.9

294

1545

N03AX12

ATC

[U] gabapentin; oral

1.6

24.9

643

4245

SPAT1097

SPAT

Recording of ECG

1.6

24.8

589

3809

L08

ICPC

Shoulder symptom/complaint

1.5

24.7

928

6663

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

24.6

2012

16719

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

24.5

321

1748

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

24.3

1387

10802

R74

ICPC

Upper respiratory infection acute

1.5

24.3

1109

8282

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

24.1

2629

22943

R4110, ,

SPAT

1.6

23.9

570

3688

R52.9

ICD-10 Finland

Pain, unspecified

1.8

23.8

418

2491

XF402

NOMESCO Finland

ECG with work load test

1.7

23.6

427

2567

Z97.4

ICD-10 Finland

Presence of external hearing-aid

2.1

23.5

218

1048

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

22.9

964

7071

P01AB01

ATC

metronidazole; oral, rectal

1.4

22.8

1492

11873

L12

ICPC

Hand/finger symptom/complaint

1.6

22.7

663

4499

SPAT1263

SPAT

Sampling

1.4

22.5

1546

12396

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

21.9

761

5358

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

21.9

858

6196

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

21.9

482

3052

J01CA04

ATC

amoxicillin; systemic

1.5

21.8

3057

27624

H01

ICPC

Ear pain/earache

1.7

21.8

430

2644

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

21.8

1733

14223

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

21.7

215

1060

U02

ICPC

Urinary frequency/urgency

1.6

21.7

616

4149

D06

ICPC

Abdominal pain localized other

1.8

21.7

351

2041

L04

ICPC

Chest symptom/complaint

1.9

21.7

274

1474

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

21.6

750

5278

A02BC01

ATC

omeprazole; systemic

1.4

21.5

1030

7729

N03AX11

ATC

topiramate; oral

2.9

21.5

101

354

J20

ICD-10 Finland

Acute bronchitis

1.7

21.5

400

2421

R06AE07

ATC

cetirizine; oral

1.4

21.2

1613

13122

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

21.0

976

7275

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

21.0

487

3121

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

21.0

845

6127

H91.9

ICD-10 Finland

Hearing loss, unspecified

2.0

21.0

224

1136

L02

ICPC

Back symptom/complaint

1.7

21.0

386

2328

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

3.2

20.8

270

C10AA05

ATC

atorvastatin; oral

1.4

20.8

1645

13455

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.1

20.7

198

964

I95.1

ICD-10 Finland

Orthostatic hypotension

2.2

20.2

170

787

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

3.8

20.1

163

D01

ICPC

Abdominal pain/cramps general

1.6

20.0

458

2925

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

19.9

1101

8460

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.0

19.9

207

1040

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

19.8

2381

20744

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

19.8

1639

13470

D09

ICPC

Nausea

2.2

19.7

174

821

R21

ICPC

Throat symptom/complaint

1.5

19.6

671

4698

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

19.6

417

2612

J02AC01

ATC

fluconazole; systemic

1.4

19.6

1455

11742

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

19.6

2418

21137

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

19.5

583

3963

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.1

19.5

198

985

H81.8

ICD-10 Finland

Other disorders of vestibular function

19.5

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

19.4

244

1309

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

19.4

930

6961

N06AX21

ATC

duloxetine; oral

1.6

19.4

456

2932

K80

ICPC

Cardiac arrhythmia NOS

1.7

19.1

355

2144

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.1

19.1

179

864

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.4

19.1

127

531

L15

ICPC

Knee symptom/complaint

1.4

19.1

984

7458

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

19.0

684

4839

SPAT1043

SPAT

Audiometry

1.7

19.0

402

2516

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

18.9

1031

7889

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

18.9

132

564

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

18.9

839

6185

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

18.8

1206

9489

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.2

18.7

157

726

R06AE53

ATC

cyclizine, combinations; systemic

4.5

18.7

101

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

3.4

18.4

197

L13

ICPC

Hip symptom/complaint

1.5

18.4

792

5801

J01DA01

ATC

[U] cefalexin

1.3

18.3

2255

19603

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.9

18.1

237

1289

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

18.1

2621

23336

D02

ICPC

Abdominal pain epigastric

1.9

18.0

251

1392

R35

ICD-10 Finland

Polyuria

1.8

18.0

267

1510

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

18.0

462

3032

N05BA04

ATC

oxazepam; oral

1.4

18.0

979

7481

J01FA06

ATC

roxithromycin; oral

1.4

17.9

1454

11858

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

17.8

423

2724

M02AA07

ATC

piroxicam; topical

1.4

17.8

1345

10843

G43.8

ICD-10 Finland

Other migraine

3.3

17.7

202

R06.4

ICD-10 Finland

Hyperventilation

3.3

17.7

207

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

17.6

223

1200

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

17.6

282

1633

A03

ICPC

Fever

1.5

17.6

560

3856

Z71.8

ICD-10 Finland

Other specified counselling

1.4

17.5

1225

9750

K59.0

ICD-10 Finland

Constipation

1.9

17.4

225

1218

K08.80

ICD-10 Finland

Toothache NOS

1.7

17.4

315

1888

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

17.4

410

2633

XKD00

NOMESCO Finland

Uroflowmetry

1.5

17.4

513

3475

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

17.3

257

1454

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.9

17.3

284

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.6

17.3

386

2447

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

2.1

17.3

157

750

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.9

17.2

225

1223

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

17.2

505

3416

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

17.2

409

2635

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

17.1

621

4391

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

17.0

522

3563

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.3

17.0

135

610

H66.9

ICD-10 Finland

Otitis media, unspecified

1.9

17.0

207

1099

C10AA07

ATC

rosuvastatin; oral

1.4

16.9

1268

10193

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

16.9

385

2454

R01AD12

ATC

fluticasone furoate; nasal

1.4

16.8

1055

8238

D11

ICPC

Diarrhoea

1.6

16.8

420

2738

K02.1

ICD-10 Finland

Caries of dentine

1.3

16.7

2043

17633

A98

ICPC

Health maint/preventive medicine

1.9

16.7

3758

35993

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

16.6

392

2519

M79.7

ICD-10 Finland

Fibromyalgia

2.2

16.6

143

669

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.9

16.5

231

1283

C09CA06

ATC

candesartan; oral

1.4

16.5

907

6925

R03BA08

ATC

ciclesonide; inhalant

1.7

16.4

328

2021

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.8

16.4

265

1539

S29

ICPC

Skin symptom/complaint other

1.4

16.3

776

5775

M54.3

ICD-10 Finland

Sciatica

1.8

16.3

232

1296

SPAT1312

SPAT

General health counselling

1.4

16.3

1102

8705

A01

ICPC

Pain general/multiple sites

1.6

16.3

401

2604

WZC00, ,

SPAT

1.5

16.1

542

3772

D82

ICPC

Teeth/gum disease

1.3

16.0

1265

10227

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

16.0

1057

8311

DFE00

NOMESCO Finland

Insertion of cochlear implant

11.7

16.0

H13

ICPC

Plugged feeling ear

1.4

16.0

735

5436

J01

ICD-10 Finland

Acute sinusitis

1.9

15.9

202

1089

C01DA14

ATC

isosorbide mononitrate; oral

1.5

15.8

563

3965

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

15.7

853

6490

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.2

15.7

135

631

C08CA01

ATC

amlodipine; oral

1.3

15.6

1481

12286

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

15.5

962

7486

SFA10

NOMESCO Finland

One-surface restoration

1.3

15.5

1929

16623

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

15.4

301

1841

C05AA08

ATC

fluocortolone; rectal, topical

1.5

15.4

487

3344

SPAT1104

SPAT

Monitoring of emergency patient

1.8

15.4

250

1454

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.7

15.3

278

1669

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.1

15.3

153

759

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.0

15.1

157

789

H02AB07

ATC

prednisone; oral

1.5

15.0

493

3411

SFA30

NOMESCO Finland

Three-surface restoration

1.3

15.0

1495

12476

L28

ICPC

Limited function/disability (L)

1.4

14.9

765

5763

X58

ICD-10 Finland

Exposure to other specified factors

1.5

14.8

490

3394

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

14.7

363

2355

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

14.7

501

3492

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.1

14.7

133

635

WW200, ,

SPAT

1.3

14.7

1114

8928

7804A

ICD-9 Finland

General symptoms, Dizziness and giddiness

3.3

14.6

160

R29

ICPC

Respiratory symptom/complaint other

1.7

14.6

254

1506

H80.1

ICD-10 Finland

Otosclerosis involving oval window, obliterative

+∞

14.6

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

14.6

619

4504

WX290

NOMESCO Finland

Other blockage of nerve

1.3

14.5

1545

12991

U07

ICPC

Urine symptom/complaint other

1.6

14.5

330

2101

M01AX17

ATC

nimesulide; oral

1.4

14.5

875

6768

N02BF01

ATC

gabapentin; oral

1.6

14.4

393

2609

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

14.4

265

1595

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

14.4

649

4773

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

14.4

155

790

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.0

14.3

219

G04BD12

ATC

mirabegron; oral

1.5

14.3

480

3333

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.4

14.3

398

R31

ICD-10 Finland

Unspecified haematuria

1.6

14.3

354

2299

S02

ICPC

Pruritus

2.1

14.3

138

676

SFA20

NOMESCO Finland

Two-surface restoration

1.3

14.2

2025

17679

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

14.2

129

617

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

14.2

797

6089

P06

ICPC

Sleep disturbance

1.5

14.2

436

2974

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.1

14.1

141

699

M02AA10

ATC

ketoprofen; topical

1.4

14.0

580

4196

M75.8

ICD-10 Finland

Other shoulder lesions

2.0

14.0

147

742

D10

ICPC

Vomiting

1.9

14.0

173

924

M48.0

ICD-10 Finland

Spinal stenosis

1.5

13.9

471

3276

R25.2

ICD-10 Finland

Cramp and spasm

2.3

13.9

428

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

13.9

152

779

M54

ICD-10 Finland

Dorsalgia

1.5

13.9

427

2913

J01MA12

ATC

levofloxacin; systemic

1.4

13.8

657

4875

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

13.8

232

1362

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.6

13.8

297

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

13.7

886

6915

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

2.7

13.7

286

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

3.7

13.7

118

P03

ICPC

Feeling depressed

1.6

13.7

301

1899

SPAT1310

SPAT

Counselling related to known health issue

1.3

13.7

1116

9023

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

13.7

919

7219

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

13.7

905

7093

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

13.6

463

3223

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

13.6

507

3594

R03BA02

ATC

budesonide; inhalant

1.4

13.5

632

4676

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.9

13.5

216

DE2CF

NOMESCO Finland

Acoustic channel extensive MRI examination with median intensity magnet

140.5

13.5

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

13.4

275

1704

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

13.3

558

4047

C03EA02

ATC

trichlormethiazide and potassium-sparing agents; oral

2.6

13.3

303

N03AX09

ATC

lamotrigine; oral

2.0

13.2

145

744

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

13.2

277

1727

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

13.2

652

4870

SPAT1254

SPAT

Administration of medicine

1.5

13.1

526

3782

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

13.1

1346

11220

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

13.1

317

2049

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

13.1

1478

12478

S22.3

ICD-10 Finland

Fracture of rib

1.7

13.0

257

1577

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

13.0

178

984

N06AB04

ATC

citalopram; systemic

1.4

13.0

728

5552

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

2.9

13.0

199

N30.0

ICD-10 Finland

Acute cystitis

1.4

12.9

656

4920

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

12.9

330

2160

M54.8

ICD-10 Finland

Other dorsalgia

1.9

12.8

169

922

A02BC04

ATC

rabeprazole; oral

1.6

12.8

313

2025

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

12.8

213

1247

J01CA08

ATC

pivmecillinam; oral

1.3

12.8

1535

13046

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

12.8

684

5173

U05

ICPC

Urination problems other

1.8

12.8

205

1188

DFX00

NOMESCO Finland

Connecting cochlear implant

11.6

12.8

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.0

12.7

133

671

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.8

12.7

186

1049

ACC51

NOMESCO Finland

Release of median nerve

1.6

12.7

278

1752

N06AA09

ATC

amitriptyline; systemic

1.5

12.7

355

2370

C07AB02

ATC

metoprolol; systemic

1.4

12.6

722

5519

N06AX16

ATC

venlafaxine; oral

1.5

12.6

473

3357

C01CA24

ATC

epinephrine; parenteral

1.7

12.6

208

1216

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

12.5

339

2247

B01AC04

ATC

clopidogrel; oral

1.4

12.5

587

4340

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.3

12.5

423

38699, ,

ICD-8 Finland

+∞

12.5

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

12.5

967

7742

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

12.5

304

1967

S82

ICPC

Naevus/mole

1.4

12.4

506

3646

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.3

12.4

136

SPAT1153

SPAT

Removal of sutures

1.3

12.4

1137

9318

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.0

12.4

139

719

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

12.4

207

1214

N06AB10

ATC

escitalopram; oral

1.4

12.3

646

4866

H81

ICPC

Excessive ear wax

1.4

12.3

649

4893

N05AH04

ATC

quetiapine; oral

1.4

12.3

565

4162

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

12.2

391

2687

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

12.2

1022

8270

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

12.1

509

3687

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

12.1

285

1829

H53.2

ICD-10 Finland

Diplopia

2.0

12.1

124

622

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

12.0

706

5418

K58

ICD-10 Finland

Irritable bowel syndrome

2.2

12.0

431

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

12.0

1481

12607

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

11.9

152

821

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

11.9

290

1875

R03DC03

ATC

montelukast; oral

1.4

11.9

564

4175

R52.2

ICD-10 Finland

Other chronic pain

1.9

11.9

140

737

R50.9

ICD-10 Finland

Fever, unspecified

1.4

11.9

508

3693

A06AC51

ATC

ispaghula, combinations; oral

1.8

11.9

173

975

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

11.9

264

1671

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

11.8

217

1307

N89

ICPC

Migraine

2.2

11.8

101

473

H60

ICD-10 Finland

Otitis externa

1.8

11.6

171

966

R06AX27

ATC

desloratadine; oral

1.3

11.6

932

7487

A97

ICPC

No disease

1.4

11.6

717

5542

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

11.6

330

2212

H60.8

ICD-10 Finland

Other otitis externa

2.1

11.6

111

543

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

11.6

399

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

11.6

196

1155

SPAT1360

SPAT

Extensive global examination

1.6

11.5

242

1510

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.9

11.5

135

710

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.3

11.5

400

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

11.5

1329

11206

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

11.4

240

1499

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

11.3

362

2488

L14

ICPC

Leg/thigh symptom/complaint

1.6

11.3

300

1980

DHB50

NOMESCO Finland

Turbinoplasty

2.3

11.3

384

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

11.2

423

3001

J01DC02

ATC

cefuroxime; systemic

1.8

11.2

181

1051

CS494

NOMESCO Finland

Other visual field testing

2.1

11.2

101

483

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

11.2

325

2188

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

11.2

709

5501

R07.0

ICD-10 Finland

Pain in throat

1.7

11.1

223

1376

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.5

11.1

402

2833

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.5

11.1

264

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

2.5

11.0

288

P01

ICPC

Feeling anxious/nervous/tense

1.5

11.0

343

2343

R13

ICD-10 Finland

Dysphagia

1.6

11.0

265

1710

H71

ICD-10 Finland

Cholesteatoma of middle ear

3.1

11.0

147

TAB00

NOMESCO Finland

Lumbar puncture

1.9

11.0

146

800

N02CC05

ATC

almotriptan; oral

2.0

11.0

118

602

K07.60

ICD-10 Finland

Snapping jaw

1.8

10.9

168

963

J02AC02

ATC

itraconazole; systemic

1.4

10.9

606

4605

N06AX26

ATC

vortioxetine; oral

1.6

10.8

230

1439

J01EA01

ATC

trimethoprim; systemic

1.3

10.8

946

7679

S00.0

ICD-10 Finland

Superficial injury of scalp

2.1

10.8

443

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

10.8

243

1542

L05

ICPC

Flank/axilla symptom/complaint

1.6

10.8

235

1479

78050

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Vertigo

3.0

10.8

154

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

10.7

231

1451

L50.9

ICD-10 Finland

Urticaria, unspecified

1.9

10.7

130

692

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

10.7

650

5009

AA1BG, ,

SPAT

2.3

10.7

330

L50.8

ICD-10 Finland

Other urticaria

2.5

10.6

275

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

10.6

278

1830

A04AA01

ATC

ondansetron; systemic, rectal

1.5

10.6

301

2017

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.5

10.6

246

SDA03

NOMESCO Finland

Periodontal treatment

1.3

10.6

1369

11672

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

10.5

113

577

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.7

10.5

205

1256

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

10.5

230

1451

SGA01

NOMESCO Finland

Emergency treatment

1.4

10.5

485

3572

I20.09

ICD-10 Finland

Unstable angina

1.7

10.4

194

1173

D12

ICPC

Constipation

1.8

10.4

142

785

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

10.4

3328

31533

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

10.4

215

1337

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

10.4

255

1653

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

10.4

1293

10967

D03

ICPC

Heartburn

1.9

10.4

138

757

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

10.4

242

1550

R25.1

ICD-10 Finland

Tremor, unspecified

2.0

10.4

116

601

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

10.4

163

941

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.1

10.3

438

M01AH01

ATC

celecoxib; oral

1.4

10.3

629

4844

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

10.3

424

3058

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

10.3

329

2261

J01DA09

ATC

[U] cefadroxil

1.3

10.2

856

6903

J45

ICD-10 Finland

Asthma

1.5

10.2

354

2473

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

10.2

322

2207

N62

ICD-10 Finland

Hypertrophy of breast

1.8

10.2

141

784

N05CF01

ATC

zopiclone; oral

1.3

10.2

1150

9637

K85

ICPC

Elevated blood pressure

1.3

10.1

634

4902

G04CA02

ATC

tamsulosin; oral

1.3

10.1

685

5358

D33.30

ICD-10 Finland

Acoustic neuroma

3.7

10.1

N03AE01

ATC

clonazepam; systemic

1.7

10.1

198

1214

M77.1

ICD-10 Finland

Lateral epicondylitis

1.6

10.1

238

1529

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

10.0

320

2197

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

10.0

298

2016

H01.0

ICD-10 Finland

Blepharitis

1.6

10.0

224

1421

SPAT1283

SPAT

Restricted health certificate

1.4

10.0

419

3032

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

9.9

1389

11926

SPAT1260

SPAT

Consultation of another employee

1.4

9.9

597

4589

N04BC05

ATC

pramipexole; oral

1.5

9.9

281

1882

R60.0

ICD-10 Finland

Localized oedema

1.4

9.9

471

3485

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

9.8

162

949

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

2.6

9.8

214

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

9.8

654

5106

H81

ICD-10 Finland

Disorders of vestibular function

8.7

9.8

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

9.8

384

2747

FN1AD

NOMESCO Finland

CT of coronary arteries

2.3

9.7

293

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

9.7

368

2613

R03BA05

ATC

fluticasone; inhalant

1.4

9.7

591

4549

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.2

9.7

344

P20

ICPC

Memory disturbance

1.4

9.7

542

4118

R06AE09

ATC

levocetirizine; oral

1.4

9.7

452

3333

H57.1

ICD-10 Finland

Ocular pain

1.8

9.7

131

723

DE2CM

NOMESCO Finland

Acoustic channel extensive MRI examination with 3 Tesla magnet

7.4

9.7

G04CB01

ATC

finasteride; oral

1.5

9.7

309

2122

H25.8

ICD-10 Finland

Other senile cataract

1.4

9.7

426

3110

R83

ICPC

Respiratory infection other

1.3

9.7

745

5935

L86

ICPC

Back syndrome with radiating pain

1.6

9.6

220

1402

N05BA12

ATC

alprazolam; oral

1.5

9.6

334

2332

M01AC06

ATC

meloxicam; systemic, rectal

1.3

9.6

1289

11003

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

9.6

451

3328

C10AA01

ATC

simvastatin; oral

1.2

9.6

1508

13102

J01FF01

ATC

clindamycin; systemic

1.3

9.6

914

7490

W19

ICD-10 Finland

Unspecified fall

1.5

9.6

335

2344

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

9.5

330

2304

R00.8

ICD-10 Finland

Other and unspecified abnormalities of heart beat

2.5

9.5

223

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

9.5

750

5994

P25

ICPC

Phase of life problem adult

1.8

9.5

129

714

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

9.4

703

5575

38599

ICD-8 Finland

Ménière's disease

+∞

9.4

3861A

ICD-9 Finland

Vertiginous syndromes and other disorders of vestibular system, Other and unspecified peripheral vertigo

+∞

9.4

H80.8

ICD-10 Finland

Other otosclerosis

+∞

9.4

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

9.4

934

7694

M01AH02

ATC

rofecoxib; oral

1.4

9.3

440

3249

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

9.3

436

H25.0

ICD-10 Finland

Senile incipient cataract

1.6

9.3

245

1614

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

9.3

262

1752

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.1

9.3

443

EB1VA, ,

NOMESCO Finland

1.3

9.3

585

4524

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

4.5

9.3

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

9.3

236

1543

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.8

9.3

136

770

ZYC01, ,

SPAT

1.5

9.3

339

2392

A99

ICPC

Disease/condition unspecnature/site

1.4

9.3

370

2654

J34.2

ICD-10 Finland

Deviated nasal septum

1.7

9.3

159

942

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

9.2

203

1283

C10AX09

ATC

ezetimibe; oral

1.3

9.2

593

4602

G43

ICD-10 Finland

Migraine

1.8

9.2

140

802

WZC30, ,

SPAT

1.5

9.1

301

2081

A03FA02

ATC

cisapride; oral, rectal

1.5

9.1

259

1736

N03AG01

ATC

valproic acid; systemic, rectal

1.7

9.1

181

1115

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

9.1

339

2400

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

9.1

215

1383

Z00.8

ICD-10 Finland

Other general examinations

1.5

9.0

257

1724

SPAT1216

SPAT

Assessment of functional ability

1.3

9.0

557

4296

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.7

9.0

176

1080

A27

ICPC

Fear of other disease NOS

1.6

8.9

183

1136

E0000UV, ,

ATC

1.2

8.9

1453

12648

H83.0

ICD-10 Finland

Labyrinthitis

24.1

8.9

R30.0

ICD-10 Finland

Dysuria

1.7

8.9

147

862

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

8.9

226

1478

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

8.9

202

1288

C10AA03

ATC

pravastatin; oral

1.5

8.8

253

1700

Z01.7

ICD-10 Finland

Laboratory examination

1.3

8.8

571

4434

D25

ICPC

Abdominal distension

2.1

8.8

372

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

8.8

623

4901

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

8.8

266

1808

WX002

NOMESCO Finland

Sedation and analgesia

1.3

8.8

666

5289

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

8.8

190

1197

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

8.7

440

R06.2

ICD-10 Finland

Wheezing

1.7

8.7

145

851

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

8.7

1507

13189

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.6

8.7

215

1396

M54.1

ICD-10 Finland

Radiculopathy

1.8

8.7

135

778

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

8.7

1326

11454

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

8.7

397

2917

R01AD11

ATC

triamcinolone; nasal

1.5

8.6

276

1896

H61.2

ICD-10 Finland

Impacted cerumen

1.5

8.6

240

1601

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.7

8.6

156

938

K29.7

ICD-10 Finland

Gastritis, unspecified

1.8

8.6

123

691

N02BF02

ATC

pregabalin; oral

1.5

8.6

230

1521

E66

ICD-10 Finland

Obesity

1.7

8.6

167

1023

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

2.7

8.6

158

K07.61

ICD-10 Finland

Cracking jaw joint

2.3

8.6

291

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

8.6

290

2016

N02CC02

ATC

naratriptan; oral

2.3

8.5

260

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.7

8.5

159

964

J01DA06

ATC

[U] cefuroxime

1.4

8.5

463

3499

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

1.9

8.5

108

585

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

8.5

478

3632

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.7

8.5

140

821

UJC12

NOMESCO Finland

Flexible oesophagoscopy

3.2

8.5

100

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.9

8.5

100

529

D19

ICPC

Teeth/gum symptom/complaint

1.3

8.5

1000

8391

D07AC13

ATC

mometasone; topical

1.3

8.5

961

8027

R09.1

ICD-10 Finland

Pleurisy

2.3

8.5

280

I49.1

ICD-10 Finland

Atrial premature depolarization

1.7

8.4

140

822

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

8.4

1791

15995

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.6

8.4

212

1385

M35.7

ICD-10 Finland

Hypermobility syndrome

2.6

8.4

189

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.7

8.4

162

992

H60.3

ICD-10 Finland

Other infective otitis externa

2.1

8.4

393

3870A

ICD-9 Finland

Otosclerosis involving oval window, nonobliterative

+∞

8.3

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.7

8.3

156

947

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

8.3

164

1009

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

3.0

8.3

117

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.5

8.3

256

1747

XQ820

NOMESCO Finland

Exposure to medicinal substance

4.1

8.2

XQ800

NOMESCO Finland

Prick test

1.5

8.2

215

1415

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.9

8.2

492

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

8.2

462

3509

U01

ICPC

Dysuria/painful urination

1.5

8.2

275

1907

S92.3

ICD-10 Finland

Fracture of metatarsal bone

1.8

8.2

116

650

K29

ICPC

Cardiovascular sympt/complt other

1.7

8.2

156

951

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

8.2

2301

21093

K02

ICPC

Pressure/tightness of heart

2.0

8.2

451

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.0

8.2

465

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

8.2

109

600

FP1B5, ,

SPAT

1.9

8.2

104

564

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

8.2

257

1760

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.0

8.2

431

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.0

8.1

113

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.5

8.1

192

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

1.9

8.1

516

G25.0

ICD-10 Finland

Essential tremor

1.9

8.1

516

AXX01, ,

SPAT

1.7

8.1

151

916

AA1CG, ,

SPAT

2.7

8.1

152

N02CC06

ATC

eletriptan; oral

1.9

8.1

101

545

R04

ICPC

Breathing problem other

1.7

8.1

136

803

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.2

8.1

286

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.5

8.0

205

IHZ05, ,

SPAT

1.8

8.0

108

596

DE2DG

NOMESCO Finland

Acoustic channel very extensive MRI examination with high intensity magnet

8.9

8.0

H83.9

ICD-10 Finland

Disease of inner ear, unspecified

22.1

8.0

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.3

8.0

493

3797

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.7

8.0

127

737

C08CA13

ATC

lercanidipine; oral

1.3

8.0

522

4055

J05AB11

ATC

valaciclovir; oral

1.3

8.0

492

3789

H83.3

ICD-10 Finland

Noise effects on inner ear

4.1

8.0

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

8.0

278

1944

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

7.9

533

4157

N76.0

ICD-10 Finland

Acute vaginitis

1.6

7.9

173

1093

R75

ICPC

Sinusitis acute/chronic

1.6

7.9

158

976

C08DA01

ATC

verapamil; systemic

1.7

7.9

143

861

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

7.9

112

629

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

7.9

376

2782

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

7.9

561

4412

A29

ICPC

General symptom/complaint other

1.3

7.9

470

3604

B02AA02

ATC

tranexamic acid; systemic

1.3

7.8

470

3605

R09

ICPC

Sinus symptom/complaint

1.5

7.8

259

1792

U71

ICPC

Cystitis/urinary infection other

1.5

7.8

250

1718

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

7.8

533

4168

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

3.3

7.8

K04.0

ICD-10 Finland

Pulpitis

1.5

7.8

245

1680

D07AC01

ATC

betamethasone; topical

1.2

7.8

1246

10792

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

7.8

531

G50.1

ICD-10 Finland

Atypical facial pain

2.2

7.7

304

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

7.7

274

1922

S21

ICPC

Skin texture symptom/complaint

1.3

7.7

528

4128

A02BA04

ATC

nizatidine; systemic

1.5

7.7

246

1690

H83.8

ICD-10 Finland

Other specified diseases of inner ear

45.1

7.7

H03AA01

ATC

levothyroxine sodium; systemic

1.3

7.7

828

6862

K04.09

ICD-10 Finland

Pulpit UNS

1.7

7.7

127

746

OAB93, ,

SPAT

1.6

7.7

166

1046

R06.5

ICD-10 Finland

Mouth breathing

1.5

7.7

265

1850

R07.2

ICD-10 Finland

Precordial pain

2.0

7.6

386

Z00.0

ICD-10 Finland

General medical examination

1.3

7.6

633

5079

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.7

7.6

141

854

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

7.6

402

3023

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.8

7.6

106

592

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.7

7.6

124

726

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.7

7.6

119

689

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

1.8

7.6

114

652

S04

ICPC

Lump/swelling localized

1.4

7.6

368

2732

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

7.5

997

8455

L29.8

ICD-10 Finland

Other pruritus

2.3

7.5

224

D01AE16

ATC

amorolfine; topical

1.4

7.5

390

2924

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

3.2

7.5

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.7

7.5

134

804

DCD00

NOMESCO Finland

Myringoplasty

3.2

7.5

L57.0

ICD-10 Finland

Actinic keratosis

1.4

7.5

392

2943

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.4

7.5

273

1925

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

7.5

885

7411

K74

ICPC

Ischaemic heart dis with angina

2.4

7.5

206

M01AX05

ATC

glucosamine; oral

1.3

7.5

701

5712

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

3.7

7.5

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

7.4

127

753

S02CA02

ATC

flumetasone and antiinfectives; otic

1.6

7.4

172

1102

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.0

7.4

397

M01AB55

ATC

diclofenac, combinations; oral

1.5

7.4

230

1571

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1.7

7.4

123

723

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

7.4

305

2199

DFF16

NOMESCO Finland

Speech-in-noise audiometry

7.6

7.4

P76

ICPC

Depressive disorder

1.5

7.4

190

1249

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

7.3

544

4300

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.5

7.3

166

G44.8

ICD-10 Finland

Other specified headache syndromes

2.4

7.3

190

I84.5

ICD-10 Finland

External hemorrhoids without complication

1.8

7.3

534

XG410

NOMESCO Finland

Flow-volume spirometry

1.7

7.3

124

734

G04CA01

ATC

alfuzosin; oral

1.4

7.3

335

2463

3860A

ICD-9 Finland

Vertiginous syndromes and other disorders of vestibular system, Ménière's disease

+∞

7.3

DFA00

NOMESCO Finland

Saccotomy

+∞

7.3

DFD30

NOMESCO Finland

Closure of perilymphatic fistula

+∞

7.3

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.2

7.3

279

R63.4

ICD-10 Finland

Abnormal weight loss

1.6

7.3

144

889

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.0

7.2

387

N29

ICPC

Neurological sympt/complt other

2.1

7.2

326

S80.0

ICD-10 Finland

Contusion of knee

1.5

7.2

240

1663

Z25.1

ICD-10 Finland

Need for immunization against influenza

1.6

7.2

171

1102

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

7.2

376

2822

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

7.2

352

2614

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

4.3

7.2

R06AX22

ATC

ebastine; oral

1.3

7.2

544

4311

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

7.2

655

5317

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.4

7.2

204

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.4

7.2

198

K27

ICPC

Fear cardiovascular disease other

2.5

7.2

162

N05BA01

ATC

diazepam; systemic, rectal

1.3

7.1

413

3150

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

1.7

7.1

112

649

M01AC01

ATC

piroxicam; systemic, rectal

1.3

7.1

437

3365

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.6

7.1

146

911

WX320

NOMESCO Finland

Spinalanesthesy

1.2

7.1

858

7203

ULC02

NOMESCO Finland

Hysteroscopy

1.6

7.1

160

1021

N02CC03

ATC

zolmitriptan; nasal, oral

1.6

7.0

154

974

SPAT1301

SPAT

No procedures

1.2

7.0

1057

9074

G01AF05

ATC

econazole; vaginal

1.5

7.0

243

1697

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.5

7.0

251

1764

K04.08

ICD-10 Finland

Other specified pulpit

1.5

7.0

212

1441

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

7.0

234

1623

M22.4

ICD-10 Finland

Chondromalacia patellae

1.9

7.0

448

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

7.0

258

1824

C09CA01

ATC

losartan; oral

1.2

7.0

912

7713

G04BD08

ATC

solifenacin; oral

1.5

7.0

227

1566

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

7.0

514

4058

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

7.0

471

3674

T75.4

ICD-10 Finland

Effects of electric current

3.5

7.0

J01DA08

ATC

[U] cefaclor

1.4

7.0

280

2011

G43.3

ICD-10 Finland

Complicated migraine

2.3

7.0

226

N76

ICD-10 Finland

Other inflammation of vagina and vulva

2.6

7.0

141

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

6.9

1244

10867

L84

ICPC

Back syndrome without radiat pain

1.6

6.9

163

1050

L29

ICPC

Musculoskeletal sympt/complt other

1.4

6.9

307

2245

M01AB51

ATC

indometacin, combinations; oral, rectal

1.9

6.9

394

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

6.9

198

1333

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.1

6.9

279

SPAT1211

SPAT

Application of soft bandage

1.4

6.9

280

2017

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.6

6.9

159

1020

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

6.9

1199

10446

R15

ICD-10 Finland

Faecal incontinence

1.8

6.9

106

612

WX722

NOMESCO Finland

PEEP

1.6

6.8

142

887

A05

ICPC

Feeling ill

1.6

6.8

165

1069

A23

ICPC

Risk factor NOS

1.4

6.8

284

2053

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

6.8

539

J01MA06

ATC

norfloxacin; oral

1.3

6.8

438

3394

K04

ICPC

Palpitations/awareness of heart

1.5

6.8

179

1183

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

6.8

884

7475

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.0

6.8

321

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.7

6.7

112

660

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

6.7

1202

10491

J01FA01

ATC

erythromycin; systemic

1.3

6.7

389

2968

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.0

6.7

329

F32

ICD-10 Finland

Depressive episode

1.6

6.7

149

947

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

6.7

323

2395

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

6.7

390

2979

UJD02

NOMESCO Finland

Gastroscopy

1.6

6.7

159

1027

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

6.7

243

1715

K04.00

ICD-10 Finland

Hyperemia of pulp

1.7

6.7

127

777

L90

ICPC

Osteoarthrosis of knee

1.4

6.6

248

1759

P02

ICPC

Acute stress reaction

1.6

6.6

140

879

-54

ICPC

Repair/fix-suture/cast/prosth device

2.0

6.6

365

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.7

6.6

124

755

X14

ICPC

Vaginal discharge

2.2

6.6

257

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

6.6

733

6086

L60.0

ICD-10 Finland

Ingrowing nail

1.6

6.6

150

958

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

6.6

230

1610

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.1

6.6

304

R51.81

ICD-10 Finland

Facial pain NOS

1.9

6.6

429

-48

ICPC

Clarification/discussion RFE/demand

2.0

6.6

345

L76

ICPC

Fracture: other

1.7

6.6

116

695

SPAT1161

SPAT

Ultrasound examination of urinary bladder

3.6

6.6

N32.0

ICD-10 Finland

Bladder-neck obstruction

3.1

6.6

K10.3

ICD-10 Finland

Alveolitis of jaws

1.6

6.6

134

834

R32

ICD-10 Finland

Unspecified urinary incontinence

1.7

6.6

104

605

N03AX18

ATC

lacosamide; systemic

3.2

6.6

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

6.6

1015

8732

R01AD05

ATC

budesonide; nasal

1.4

6.5

234

1646

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

6.5

568

4582

K92.0

ICD-10 Finland

Haematemesis

1.9

6.5

402

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.6

6.5

151

969

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

1.9

6.5

395

EMB10

NOMESCO Finland

Tonsillectomy

1.6

6.5

128

789

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

6.5

218

1514

R06AX13

ATC

loratadine; oral

1.3

6.5

448

3505

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.8

6.5

518

AA3AD

NOMESCO Finland

CT of face

2.7

6.5

123

L29.9

ICD-10 Finland

Pruritus, unspecified

1.8

6.5

555

183

Kela drug reimbursment

Lamotrigin and topiramate

3.0

6.5

J04.0

ICD-10 Finland

Acute laryngitis

1.8

6.5

570

B01AA03

ATC

warfarin; systemic

1.3

6.5

615

5016

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

6.4

152

980

N63

ICD-10 Finland

Unspecified lump in breast

1.5

6.4

216

1501

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.7

6.4

117

707

R78

ICPC

Acute bronchitis/bronchiolitis

2.0

6.4

348

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

3.2

6.4

NG2AA

NOMESCO Finland

Patella X-ray examination

1.7

6.4

101

587

D07AD01

ATC

clobetasol; topical

1.3

6.4

552

4448

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.0

6.4

335

K78

ICPC

Atrial fibrillation/flutter

1.4

6.4

266

1924

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

6.4

371

2832

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

6.4

144

919

D16

ICPC

Rectal bleeding

1.9

6.4

441

A08

ICPC

Swelling

1.5

6.4

205

1413

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.7

6.4

100

581

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.6

6.3

135

850

L20

ICPC

Joint symptom/complaint NOS

1.6

6.3

124

765

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.8

6.3

501

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

6.3

581

4720

NK4EA

NOMESCO Finland

Joint X-ray examintion with load or wrench not elsewhere classified

2.6

6.3

131

L29.2

ICD-10 Finland

Pruritus vulvae

2.1

6.3

276

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

6.3

198

1360

SPAT1229

SPAT

Assessment of need for aid

1.4

6.3

257

1854

M77.4

ICD-10 Finland

Metatarsalgia

1.5

6.3

193

1319

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.2

6.2

224

N06AB03

ATC

fluoxetine; oral

1.3

6.2

379

2914

J46

ICD-10 Finland

Status asthmaticus

1.7

6.2

555

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

6.2

283

2079

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.5

6.2

190

1297

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

6.2

299

2217

Z50.1

ICD-10 Finland

Other physical therapy

1.5

6.2

173

1159

N02AJ13

ATC

tramadol and paracetamol; systemic

1.9

6.2

403

K03.00

ICD-10 Finland

Approximal wear

1.4

6.2

233

1657

F32.1

ICD-10 Finland

Moderate depressive episode

1.6

6.2

153

999

R96

ICPC

Asthma

1.4

6.1

338

2559

SPAT1240

SPAT

Therapeutic discussion

1.4

6.1

277

2032

XA402

NOMESCO Finland

ENMG

1.9

6.1

418

JF1BD

NOMESCO Finland

Very extensive small bowel CT

3.2

6.1

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

6.1

526

4236

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.4

6.1

157

N81.6

ICD-10 Finland

Rectocele

1.4

6.1

237

1694

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

2.1

6.1

246

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.7

6.1

109

657

H70.1

ICD-10 Finland

Chronic mastoiditis

4.1

6.1

H91.8

ICD-10 Finland

Other specified hearing loss

2.3

6.1

176

M01AC02

ATC

tenoxicam; systemic, rectal

1.5

6.1

156

1027

P74

ICPC

Anxiety disorder/anxiety state

1.6

6.1

122

758

N06AB06

ATC

sertraline; oral

1.4

6.0

330

2496

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

6.0

446

3522

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.4

6.0

286

2115

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

6.0

294

2184

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

6.0

186

1272

OAB44, ,

SPAT

1.4

6.0

302

2254

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

1.8

6.0

428

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

6.0

130

822

A02BA03

ATC

famotidine; systemic

1.6

6.0

116

713

S88

ICPC

Dermatitis contact/allergic

2.0

6.0

336

KMAK, ,

NOMESCO Finland

1.2

6.0

1642

14848

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.5

6.0

167

1118

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.7

6.0

100

591

R49.01

ICD-10 Finland

Functional dysphonia

1.7

6.0

576

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.7

6.0

561

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1812

11663

2.02

98.55

2.3

2.2

124.73

208.20

u/l

9.80

1729

11002

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2075

14077

2.00

96.42

5.1

3.9

29.47

91.09

ng/l

1.27

1536

10233

(3013826) Glucose [Moles/volume] in Serum or Plasma

2789

21574

1.99

81.95

5.1

6.59

6.74

mmol/l

3.78

2698

20491

(3032080) INR in Blood by Coagulation assay

2350

17291

1.88

78.88

16.9

16.0

1.26

1.27

inr

0.41

1995

14397

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3157

26461

1.95

61.01

5.4

4.5

11.45

13.07

mm/h

10.19

2954

24694

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2456

19261

1.72

57.19

6.5

7.4

1.22

1.21

mmol/l

3.90

2081

16615

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

785

4435

1.96

56.24

5.6

5.1

31.95

33.12

2.19

549

2900

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3237

27751

1.91

53.00

8.8

8.6

75.45

80.10

u/l

11.08

3060

26349

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1652

11819

1.68

52.74

2.8

2.7

59.58

66.80

u/l

0.49

1499

10939

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2228

17257

1.67

52.06

5.8

6.7

1.22

1.21

mmol/l

3.87

2028

15921

(3019225) pH of Specimen

668

3683

1.98

50.90

3.9

4.5

7.38

7.35

7.01

462

2654

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3732

33919

2.75

50.37

21.0

17.3

19.79

24.69

mg/l

21.67

3239

28206

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3589

32091

2.27

49.74

6.9

5.7

1.87

1.95

mu/l

3.32

3322

29638

(3031040) Bacteria [#/volume] in Urine by Automated count

2864

23929

1.71

47.91

6.1

5.0

142.46

2156.10

e6/l

4.66

331

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2435

19632

1.62

45.56

6.1

6.7

11.19

11.49

umol/l

0.68

2294

18731

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2726

22689

1.65

44.02

3.8

3.3

44.73

50.03

u/l

2.82

2534

21159

(3019550) Sodium [Moles/volume] in Serum or Plasma

3781

34922

2.84

43.14

24.4

20.5

139.69

139.65

mmol/l

0.42

3727

34279

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2145

16900

1.59

43.09

2.4

2.2

101.57

96.30

pmol/l

4.39

1136

8753

(3023103) Potassium [Moles/volume] in Serum or Plasma

3783

34977

2.83

42.55

24.6

20.7

3.96

3.97

mmol/l

2.65

3716

34272

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1179

8063

1.66

42.55

2.0

1.7

0.98

1.31

mg/l

4.75

906

6281

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1577

11760

1.57

38.85

3.4

3.2

1050.32

1443.16

ng/l

5.55

1345

10239

(3018010) Neutrophils/Leukocytes in Blood

2132

17017

1.55

38.60

6.5

6.4

56.86

57.71

2.69

2032

16211

(3019069) Monocytes/Leukocytes in Blood

2132

17039

1.54

38.20

6.9

6.7

8.78

8.91

1.24

2003

15915

(3018677) aPTT in Platelet poor plasma by Coagulation assay

881

5720

1.69

38.11

2.0

2.1

29.24

29.64

1.32

861

5564

(3002030) Lymphocytes/Leukocytes in Blood

2161

17355

1.54

37.62

6.7

6.6

28.13

27.30

2.96

2050

16394

(3006504) Eosinophils/Leukocytes in Blood

2123

16998

1.54

37.38

6.8

6.6

2.84

2.82

0.10

1989

15870

(3022096) Basophils/Leukocytes in Blood

2122

17003

1.53

37.12

6.9

6.7

0.70

0.68

0.77

1987

15861

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3619

33110

2.08

36.89

6.2

5.4

5.95

5.96

mmol/l

0.06

3306

30309

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3590

32819

2.01

35.61

20.2

16.9

78.31

78.20

ml/min/173m2

0.13

3388

30551

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3560

32473

1.96

35.22

7.3

6.7

39.45

39.51

mmol/mol

0.19

3277

30256

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3127

27496

1.65

35.13

5.4

4.6

14.93

14.87

pmol/l

0.73

2871

25198

(40768797) Stomach Pathology biopsy report

802

5183

1.69

34.92

1.2

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1141

8117

1.57

33.38

1.3

1.50

1.69

u/ml

0.24

256

2161

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3822

36009

2.77

32.24

27.6

22.6

76.83

77.16

umol/l

0.31

3786

35579

(3013115) Eosinophils [#/volume] in Blood

2300

19057

1.49

32.11

6.6

0.19

e9/l

1.01

2011

16511

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3797

35670

2.58

32.08

14.7

12.8

25.42

25.14

u/l

0.38

3682

34626

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

413

2246

1.94

31.87

1.4

1.3

46.87

53.00

au/ml

0.24

165

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

442

2461

1.90

31.76

2.6

2.4

19.28

22.49

au/ml

0.40

240

(3006315) Basophils [#/volume] in Blood

2236

18508

1.48

30.74

6.5

6.3

0.04

e9/l

0.03

1945

15758

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

973

6791

1.57

30.46

1.4

1.3

36.23

31.09

iu/ml

0.45

281

2070

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2090

17091

1.47

30.44

2.6

2.5

77.92

79.00

nmol/l

1.02

1866

15381

(3001604) Monocytes [#/volume] in Blood

2228

18452

1.47

30.38

6.5

6.3

0.58

0.59

e9/l

0.44

1945

15705

(3019198) Lymphocytes [#/volume] in Blood

2265

18833

1.47

30.17

6.5

6.4

2.01

1.90

e9/l

0.96

2008

16449

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2362

19830

1.47

29.74

3.1

2.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1021

7269

1.55

29.03

5.1

3.9

150.79

366.87

ng/l

4.59

785

5840

(3013650) Neutrophils [#/volume] in Blood by Automated count

2455

20816

1.47

29.01

8.7

9.8

4.12

4.14

e9/l

0.18

2143

18015

(3007164) IgA [Mass/volume] in Serum or Plasma

988

7041

1.54

27.77

1.5

2.26

2.48

g/l

2.96

563

4278

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3660

34124

1.96

27.64

6.8

6.0

2.67

2.68

mmol/l

0.27

3398

31625

(3048689) Calprotectin [Mass/mass] in Stool

684

4480

1.64

27.59

2.4

2.3

131.18

141.27

ug/g

0.32

544

3555

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3593

33345

1.84

26.91

6.0

5.2

1.45

1.49

mmol/l

8.68

3320

30802

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3609

33557

1.85

26.60

6.1

5.2

4.60

4.64

mmol/l

1.07

3350

31216

(3010813) Leukocytes [#/volume] in Blood

3844

36601

2.73

26.46

31.9

26.3

6.79

6.76

e9/l

0.22

3787

35727

(3021960) Folate [Moles/volume] in Serum or Plasma

1438

11145

1.46

26.45

1.8

1.7

20.41

20.54

nmol/l

0.12

1202

9412

(3007461) Platelets [#/volume] in Blood

3843

36594

2.71

26.31

31.9

26.3

249.91

251.80

e9/l

1.05

3796

35856

(3035941) MCH [Entitic mass]

3843

36598

2.71

26.23

31.7

26.2

30.30

30.33

0.63

3816

36194

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3843

36598

2.71

26.23

31.7

26.2

91.10

91.38

3.87

3817

36195

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3843

36600

2.71

26.19

32.2

26.7

40.21

39.88

4.48

3815

36185

(3026361) Erythrocytes [#/volume] in Blood

3843

36601

2.71

26.17

31.8

26.2

4.45

4.43

e12/l

3.00

3788

35731

(3000963) Hemoglobin [Mass/volume] in Blood

3843

36609

2.70

26.01

32.0

26.4

134.13

133.32

g/l

3.33

3816

36220

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3461

31851

1.69

25.78

5.0

4.4

1.34

1.28

mmol/l

4.90

3161

29082

(3044640) Blood type and Crossmatch panel - Blood

1529

12118

1.43

24.35

2.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2050

17114

1.41

24.24

4.2

5.1

35.87

35.34

g/l

4.60

1881

16029

(3009343) pH of Capillary blood

405

2398

1.77

23.56

3.1

3.8

7.42

0.44

335

1996

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

881

6339

1.50

23.02

1.4

1.3

15.00

11.17

u/ml

0.30

309

2396

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

412

2468

1.75

22.99

3.1

3.8

5.13

5.17

kpa

0.42

391

2367

(3026008) Bacteria identified in Urine by Culture

1526

12197

1.41

22.70

3.6

3.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2006

16844

1.39

22.03

3.4

3.1

114.44

124.73

ug/l

0.91

1841

15671

(3036481) Cortisol [Moles/volume] in Serum or Plasma

531

3480

1.61

20.93

2.2

2.3

371.37

382.31

nmol/l

0.67

478

3214

(3021601) Nitrite [Presence] in Urine by Test strip

2224

19104

1.37

20.63

4.5

4.1

0.00

estimate

0.80

463

4034

(3022313) Gas panel - Capillary blood

295

1656

1.84

20.42

3.3

3.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

351

2087

1.75

20.03

2.9

3.6

1.66

2.01

mmol/l

1.19

266

1559

(3009261) Glucose [Presence] in Urine by Test strip

2257

19483

1.37

20.01

4.6

4.2

0.00

0.08

estimate

0.57

453

3914

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1285

10134

1.40

20.01

2.6

2.4

2.82

2.88

mg/l

0.53

1111

8750

(3035350) Ketones [Presence] in Urine by Test strip

2242

19341

1.37

19.91

4.5

4.2

2.63

3.96

estimate

0.19

472

4172

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

241

1281

1.94

19.73

3.3

3.9

25.05

24.96

mmol/l

0.19

211

1169

(3022145) Colonoscopy Study observation

616

4270

1.52

18.84

1.3

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

702

5013

1.49

18.58

1.4

530.57

537.58

titre

0.03

159

1158

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

737

5334

1.47

18.19

1.6

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

1495

12229

1.36

18.09

4.0

3.4

143.28

78.32

e6/l

0.37

1170

9332

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1173

9235

1.38

18.04

2.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

328

1971

1.72

17.99

2.3

2.4

—

(3000850) Epithelial cells [#/volume] in Urine

1089

8494

1.39

17.65

3.1

2.7

5.66

5.91

e6/l

0.30

989

7740

(3026782) Osmolality of Urine

953

7273

1.41

17.54

3.5

3.0

521.79

520.50

mosm/kgh2o

0.07

836

6388

(3019309) Folate [Moles/volume] in Red Blood Cells

881

6638

1.42

17.43

1.9

1.8

1097.27

1179.54

nmol/l

1.80

660

5031

(3015736) pH of Urine

1819

15384

1.34

17.41

3.9

3.7

6.20

6.26

1.41

966

8507

(3030467) Casts [#/volume] in Urine by Automated count

1314

10606

1.36

17.07

3.9

3.3

0.46

e6/l

0.00

985

7804

(3005322) IgE [Units/volume] in Serum or Plasma

358

2237

1.66

16.95

1.4

1.3

100.57

206.85

u/ml

6.24

338

2068

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1758

14841

1.33

16.83

2.0

1.9

1.39

1.34

mmol/l

1.53

1417

12392

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1997

17171

1.33

16.83

2.9

2.8

—

estimate

—

(3018095) Leukocytes [#/volume] in Urine

1657

13871

1.33

16.80

4.7

4.0

90.52

107.89

e6/l

0.48

1225

9772

(40768804) Tissue Pathology biopsy report

1752

14798

1.33

16.65

2.4

2.2

—

(36304419) Bacteria [Presence] in Urine

1250

10051

1.36

16.52

3.8

3.2

113.98

336.20

estimate

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1611

13485

1.33

16.13

3.1

3.6

2.36

mmol/l

0.11

1440

12214

(3017732) Neutrophils [#/volume] in Blood

640

4615

1.46

15.90

2.8

3.3

4.19

4.47

e9/l

0.53

520

3958

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

260

1516

1.77

15.85

1.9

39.47

39.49

u/l

0.01

228

1346

(3003327) Ova and parasites identified in Stool by Light microscopy

215

1204

1.83

15.00

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

1165

9407

1.34

14.58

4.0

4.1

89.97

89.45

0.28

1145

9185

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

106

463

2.32

14.53

2.1

2.2

23.86

21.18

mg/l

0.24

166

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

414

2781

1.55

14.44

1.6

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

850

6556

1.38

14.27

2.1

1.9

—

(3025941) Bacteria identified in Stool by Culture

299

1876

1.64

13.90

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1172

9546

1.32

13.62

2.5

2.8

336.67

342.26

umol/l

1.06

984

8363

(3012095) Magnesium [Moles/volume] in Serum or Plasma

834

6460

1.37

13.55

2.6

3.3

0.82

0.81

mmol/l

1.07

770

6079

(36660697) Celiac disease serology panel - Serum

415

2849

1.51

13.05

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

105

479

2.22

13.03

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

101

454

2.26

12.99

1.5

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1002

8040

1.33

12.79

1.8

1.7

36005365.12

29371593.81

pmol/l

0.13

811

6663

(3013139) Helicobacter pylori Ag [Presence] in Stool

380

2572

1.53

12.77

1.3

—

(4024509) Urine culture

286

1822

1.61

12.51

2.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1214

10036

1.30

12.43

4.2

3.6

0.17

0.22

estimate

0.09

379

3163

(3025468) Yersinia sp identified in Specimen by Organism specific culture

451

2.23

12.35

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

453

2.22

12.22

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

102

473

2.19

12.18

1.5

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

587

4360

1.41

12.17

2.4

2.7

7.69

8.42

umol/l

0.23

506

3817

(3014051) Protein [Presence] in Urine by Test strip

1224

10161

1.30

12.06

3.4

3.1

0.13

0.04

0.46

278

(3024522) Salmonella sp identified in Specimen by Organism specific culture

102

475

2.18

12.06

1.5

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

776

6057

1.35

11.82

3.4

3.1

3.21

2.93

e6/l

0.28

402

2944

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

193

1125

1.75

11.82

1.4

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

1494

12787

1.27

11.38

3.4

7.31

7.12

mmol/l

0.85

1197

10764

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

837

6657

1.33

11.15

3.2

3.0

1.01

1.14

e6/l

0.66

462

3560

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

185

1089

1.73

10.96

1.3

10.00

45.82

u/ml

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1408

12019

1.27

10.81

2.9

3.3

30.08

35.68

u/l

2.52

1299

11324

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

190

1136

1.71

10.65

1.8

1.6

1.21

1.19

g/l

0.49

182

1086

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

269

1759

1.57

10.55

1.1

—

(3049717) Cytology report of Urine Cyto stain

219

1363

1.64

10.54

2.6

—

(3023368) Bacteria identified in Blood by Culture

1257

10612

1.27

10.52

4.3

4.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

175

1028

1.73

10.46

1.3

4.54

5.70

u/ml

0.12

105

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

235

1492

1.61

10.44

2.2

1.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1641

14308

1.25

10.37

4.6

4.1

0.02

0.38

estimate

0.99

385

3296

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

220

1380

1.63

10.27

2.0

1.8

—

(3045424) Erythrocytes [Presence] in Urine

279

1856

1.54

10.14

2.3

2.2

0.00

0.44

estimate

0.51

576

(3022621) pH of Urine by Test strip

408

2933

1.44

10.09

2.9

6.06

6.08

0.14

249

2029

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

351

2454

1.47

10.05

1.8

1.7

—

(3045414) Leukocytes [Presence] in Urine

498

3712

1.39

10.02

2.2

0.00

0.01

estimate

1.06

745

(3000494) Fungus identified in Specimen by Culture

577

4421

1.36

9.77

1.5

—

(3012516) Albumin [Mass/volume] in Urine

1426

12307

1.25

9.67

3.4

3.5

38.88

45.70

mg/l

0.78

848

7780

(3020682) Albumin/Creatinine [Ratio] in Urine

1446

12504

1.25

9.62

4.1

4.2

6.79

8.86

mg/mmol

1.23

836

7711

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

213

1349

1.61

9.58

1.6

18.61

17.63

u/ml

0.07

288

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

172

1032

1.70

9.55

1.3

5.40

8.31

u/ml

0.54

166

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

180

1101

1.67

9.30

1.8

1.6

0.23

0.24

g/l

0.91

173

1050

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

147

855

1.75

9.14

1.2

1.1

3.08

4.49

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

159

949

1.70

9.02

1.5

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

4.09

8.97

1.0

—

(3018418) pH of Serum or Plasma

1362

11781

1.24

8.85

3.9

4.3

7.40

0.75

958

8475

(3000570) Elastase.pancreatic [Mass/mass] in Stool

189

1196

1.61

8.56

1.5

1.4

284.31

272.82

ug/g

0.27

718

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

106

572

1.88

8.46

1.3

0.12

0.34

nmol/l

—

(40768443) Skin Pathology biopsy report

251

1704

1.51

8.33

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

383

2817

1.40

8.31

2.5

2.9

10.23

10.61

g/l

0.90

350

2597

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

156

948

1.67

8.30

1.9

2.0

11.51

12.06

mg/l

0.39

146

870

(3044290) Cell count panel - Cerebral spinal fluid

127

729

1.77

8.30

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

392

2898

1.39

8.25

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

417

3115

1.38

8.24

2.7

3.8

76.68

90.22

ng/l

4.15

354

2651

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

144

860

1.70

8.18

1.2

1.3

2.55

3.15

u/ml

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

102

550

1.88

8.17

1.3

0.63

3.86

nmol/l

0.50

529

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

135

2.83

8.10

1.1

1.0

7.01

6.72

u/ml

—

(3029937) Albumin [Presence] in Urine by Test strip

1245

10783

1.23

7.75

4.8

4.3

0.00

estimate

0.13

445

3733

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

122

2.89

7.73

1.2

0.32

0.30

g/l

1.17

100

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

425

1.95

7.43

1.5

1.4

33.22

31.50

u/l

0.15

356

(3015171) Extractable nuclear Ab [Units/volume] in Serum

216

1458

1.51

7.40

1.3

1.2

1.35

1.10

u/ml

0.09

123

(3012544) pH of Venous blood

508

3979

1.32

7.32

3.4

3.6

7.39

7.38

3.70

281

2313

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

467

3628

1.33

7.13

2.8

2.5

34.28

52.56

u/l

0.69

394

3065

(4094501) Cardiovascular stress test using bicycle ergometer

155

981

1.60

7.07

1.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

797

6638

1.25

7.04

2.4

2.7

13.45

12.67

umol/l

1.43

730

6191

(40761536) Microorganisms panel - Urine sediment

385

2915

1.36

6.99

5.1

4.2

—

(3032057) Clostridioides difficile [Presence] in Stool

3.39

6.96

1.8

2.1

—

(3002032) Base excess in Venous blood by calculation

487

3821

1.31

6.93

3.3

3.6

2.01

1.87

mmol/l

0.37

434

3338

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

451

1.88

6.88

1.2

1.1

1.61

3.28

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

235

2.23

6.78

1.2

1.3

—

(3027008) Opiates [Presence] in Urine

132

813

1.65

6.74

1.6

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

606

4911

1.28

6.72

1.9

1.8

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

145

915

1.61

6.72

1.3

1.2

438.51

571.86

mg/l

4.50

138

868

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

313

2310

1.39

6.67

2.0

1.9

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

501

1.81

6.59

1.4

1.3

263.90

309.63

pmol/l

0.94

430

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

238

2.20

6.59

1.2

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

200

2.32

6.57

1.2

1.6

6.44

8.52

ug/l

1.13

173

(3007853) Bacteria identified in Skin by Aerobe culture

538

4315

1.29

6.47

1.9

1.8

—

(3002256) Pathology report gross observation

614

5007

1.27

6.46

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

454

1.85

6.44

1.4

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

130

809

1.63

6.39

1.6

1.8

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

229

2.20

6.34

1.1

0.48

13.88

nmol/l

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

402

3109

1.33

6.33

3.0

3.1

140.06

203.21

ng/l

6.34

379

2850

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

493

1.80

6.33

1.4

1.3

0.19

0.22

nmol/l

0.37

391

(1001926) Buprenorphine [Presence] in Urine by Screen method

108

642

1.70

6.33

1.6

—

(3028300) Cannabinoids [Presence] in Urine

131

819

1.62

6.32

1.6

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

472

1.82

6.29

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

398

3078

1.33

6.27

2.6

2.5

0.27

0.50

e6/l

2.90

374

2947

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

283

2.07

6.27

1.3

1.90

2.28

mmol/l

2.60

264

(3027944) Amphetamines [Presence] in Urine

129

806

1.62

6.25

1.5

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1069

9282

1.21

6.23

6.3

5.8

2.62

2.99

ug/l

0.62

964

8341

(3016879) Cocaine [Presence] in Urine

121

746

1.64

6.18

1.6

1.8

—

(4015189) Microbial culture of sputum

2.97

6.10

1.9

2.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

547

1.74

5.97

1.1

6.40

22.26

au/ml

2.58

118

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

165

2.38

5.96

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

165

2.38

5.96

1.3

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

126

793

1.61

5.94

1.2

38.78

47.38

u/ml

0.21

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

147

2.46

5.93

1.2

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

467

1.79

5.91

1.2

1.3

—

nmol/l

—

(3000330) Specific gravity of Urine by Test strip

267

1963

1.39

5.85

3.7

3.5

1.02

ratio

0.38

246

1765

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

181

1240

1.48

5.83

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

521

1.74

5.83

1.3

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

318

2414

1.35

5.70

1.3

1.2

107.72

141.69

u/ml

1.01

119

883

(3004789) Transferrin [Mass/volume] in Serum or Plasma

735

6198

1.23

5.69

2.4

2.6

2.39

2.31

g/l

3.97

672

5727

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

336

1.92

5.67

1.2

93.80

69.18

u/ml

—

(3008898) HLA-B27 [Presence]

158

1059

1.51

5.67

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

227

2.13

5.66

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

446

3555

1.29

5.63

2.5

2.6

68.39

70.10

e9/l

0.48

346

2584

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

681

5705

1.23

5.61

2.4

2.7

22.54

22.10

0.22

622

5305

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

126

805

1.58

5.60

1.3

1.2

3.78

3.76

mmol/l

0.06

114

764

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

403

1.83

5.55

1.2

43.80

45.91

u/ml

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

265

1965

1.37

5.52

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

919

7944

1.20

5.52

2.8

3.1

2.45

2.46

mmol/l

2.98

798

7129

(3021589) Normoblasts [#/volume] in Blood

1751

16008

1.17

5.40

13.5

12.0

0.00

e9/l

2.27

1451

13011

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

302

2301

1.34

5.29

3.3

3.5

4.38

4.44

pmol/l

0.48

263

2056

(3012501) Base excess in Blood by calculation

121

777

1.57

5.29

4.3

4.6

2.61

2.72

mmol/l

0.19

545

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

332

2568

1.32

5.24

2.1

2.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

484

3934

1.26

5.21

3.4

3.6

5.80

5.82

kpa

0.18

474

3835

(3023420) DNA double strand Ab [Units/volume] in Serum

213

1544

1.40

5.11

1.7

1.8

6.35

6.73

iu/ml

0.05

368

(3011288) Drugs identified in Urine by Screen method Nominal

565

1.66

5.10

2.5

2.4

—

(3027945) Reticulocytes/Erythrocytes in Blood

551

4562

1.24

5.04

2.3

2.6

1.77

1.82

0.51

480

4052

(3006653) Thiamine [Moles/volume] in Blood

198

2.13

5.03

1.1

1.2

136.67

131.29

nmol/l

0.42

198

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

252

2.00

5.02

1.2

1.1

32.86

42.86

mg/l

1.20

212

(3023511) Choriogonadotropin [Units/volume] in Urine

425

1.76

4.98

1.5

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

165

1148

1.46

4.97

1.5

0.45

6.60

iu/ml

0.56

214

(3004119) Hemoglobin [Mass/volume] in Venous blood

318

2465

1.32

4.96

3.3

3.0

132.31

127.88

g/l

3.65

309

2397

(3028707) Methadone [Presence] in Urine by Screen method

346

1.83

4.92

1.9

2.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

397

3174

1.28

4.90

2.6

2.4

6.67

7.06

ug/l

0.16

334

2797

(1616796) Gas panel - Central venous blood

128

850

1.52

4.85

2.9

4.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

291

2235

1.33

4.85

1.7

2.0

1.19

1.40

g/l

1.49

270

2050

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

527

1.67

4.84

1.1

—

0.72

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

143

2.32

4.84

1.1

1.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

416

1.74

4.76

4.4

3.6

58.68

57.47

0.17

354

(3011985) Renin [Units/volume] in Plasma

530

1.66

4.75

1.4

22.39

58.25

mu/l

2.32

469

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

474

3886

1.25

4.74

4.1

3.6

—

(3004809) Band form neutrophils/Leukocytes in Blood

102

647

1.59

4.73

4.0

3.8

1.09

1.58

1.42

575

(4034850) Laboratory test

163

1144

1.44

4.70

7.2

10.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

541

4507

1.23

4.67

4.2

4.5

239.07

247.87

u/l

1.05

508

4266

(3027231) Wheat IgE Ab [Units/volume] in Serum

3.50

4.61

1.0

0.40

2.47

u/ml

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

183

1319

1.41

4.57

1.2

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

193

2.08

4.55

1.2

1.0

1.06

1.18

u/l

0.78

100

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.77

4.44

1.0

1.1

0.64

0.70

umol/24h

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

595

1.59

4.43

1.6

0.55

0.79

g/l

2.79

463

(3024354) Oxygen [Partial pressure] in Venous blood

406

3296

1.26

4.42

3.2

3.0

4.41

4.51

kpa

0.50

399

3205

(3022806) Fractional oxyhemoglobin in Capillary blood

456

1.68

4.42

2.5

1.9

91.11

89.51

3.00

451

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

301

1.84

4.38

1.8

1.7

420.12

331.56

mu/l

0.27

243

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

316

1.82

4.36

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

282

2191

1.31

4.35

2.3

11.64

12.62

nmol/l

1.18

241

1959

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

388

3142

1.26

4.32

3.7

4.0

1.23

mmol/l

0.16

340

2703

(44813793) Dust mix specific IgE antibody measurement

225

1.97

4.29

1.1

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

538

1.61

4.26

1.4

1.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

426

3496

1.24

4.23

5.6

7.2

1.36

1.33

mmol/l

0.23

417

3432

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

187

1374

1.38

4.19

1.8

2.1

340.62

651.15

ug/l

0.77

173

1301

(44806071) Cardiolipin IgM antibody measurement

3.86

4.19

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.91

4.16

1.9

2.1

—

(4062490) Immunoglobulin typing, IgG

358

1.74

4.16

1.5

1.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

599

5104

1.20

4.12

4.0

5.9

1.03

1.04

mmol/l

0.38

549

4730

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.57

4.04

1.1

1.0

7.08

11.26

u/ml

0.50

(40760892) CBC W Ordered Manual Differential panel - Blood

893

7889

1.17

4.04

4.8

4.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

103

682

1.52

4.02

1.8

1.9

4.33

4.81

mmol/24h

0.80

597

(3048929) Epstein Barr virus Ab [Presence] in Serum

134

939

1.44

3.96

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

134

943

1.44

3.87

1.8

1.7

357.47

301.35

mu/l

0.68

119

863

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

127

885

1.45

3.87

1.0

1.1

2.22

6.10

eliau/ml

1.07

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

115

786

1.48

3.87

1.4

1.3

11.87

35.37

e6/l

1.26

577

(3016018) Differential panel - Cerebral spinal fluid

404

1.67

3.87

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

173

1274

1.37

3.86

1.7

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

415

3432

1.23

3.85

1.9

2.8

66.19

66.30

g/l

0.10

374

3155

(3036489) Thrombin time

179

1327

1.37

3.83

1.9

21.74

21.07

0.32

152

1173

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.84

3.79

1.9

2.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

135

956

1.43

3.78

1.6

1.7

16458.23

12432.29

e6/l

0.25

652

(3027273) Bicarbonate [Moles/volume] in Venous blood

232

1793

1.31

3.76

3.7

3.2

25.46

25.33

mmol/l

0.23

223

1733

(3023323) Follitropin [Units/volume] in Serum or Plasma

197

1487

1.34

3.76

1.4

28.81

30.57

iu/l

0.30

153

1288

(3028192) IgG subclass 2 [Mass/volume] in Serum

362

1.70

3.75

1.5

1.4

2.72

2.89

g/l

0.33

267

(3024139) IgG subclass 3 [Mass/volume] in Serum

362

1.70

3.75

1.5

1.4

0.36

0.40

g/l

0.53

267

(3027135) IgG subclass 1 [Mass/volume] in Serum

362

1.70

3.75

1.5

1.4

6.33

6.73

g/l

0.43

266

(3028679) Herpes simplex virus Ab [Presence] in Serum

167

2.04

3.74

1.1

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

591

1.54

3.68

2.2

1.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

197

1.94

3.62

1.9

2.2

627.28

531.98

e6/l

0.44

160

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

115

798

1.45

3.61

1.5

1.4

360.76

1229.62

e6/l

1.21

626

(3004451) EKG impression Narrative

248

1.82

3.57

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

237

1853

1.30

3.54

1.5

1.8

1.51

1.54

g/l

0.24

196

1598

(3003181) Sodium [Moles/volume] in Urine

115

802

1.45

3.52

1.5

1.4

71.72

61.02

mmol/l

1.80

647

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

165

2.01

3.49

1.5

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

176

1325

1.34

3.44

2.6

2.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

244

1.81

3.43

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

342

1.68

3.40

2.2

3.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.52

3.39

1.0

1.2

0.05

0.03

u/ml

0.59

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

174

1.96

3.38

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

494

4213

1.20

3.37

3.2

4.2

10.25

24.59

ug/l

1.74

393

3451

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

340

2797

1.24

3.34

1.5

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

162

1.98

3.28

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

107

747

1.44

3.28

1.4

1.3

10.46

11.92

u/l

0.54

609

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

190

1.90

3.28

2.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

315

1.69

3.28

1.9

1.8

5.82

7.98

umol/l

0.52

224

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

115

2.18

3.28

3.8

3.0

27.43

29.51

umol/l

0.50

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

534

4601

1.19

3.25

2.0

1.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

251

1.76

3.16

1.3

—

(3037121) Protein [Mass/volume] in Urine

170

1298

1.32

3.06

3.7

3.2

338.03

355.00

mg/l

0.06

545

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.51

3.04

1.5

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

137

1014

1.36

3.03

1.3

1.1

—

(3042936) Bacteria identified in Isolate by Culture

609

5336

1.17

3.02

2.0

2.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

339

1.63

3.00

1.0

1.1

—

(4146454) Self-monitoring of blood glucose

410

1.57

2.98

2.8

2.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

380

1.59

2.94

3.6

4.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

137

1021

1.35

2.92

1.3

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

198

1555

1.29

2.91

1.9

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

213

1690

1.28

2.89

1.8

2.5

7.37

7.44

g/l

0.28

190

1546

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

115

2.09

2.88

1.3

1.8

—

(1761868) Lipid panel - Serum or Plasma

1344

12452

1.12

2.86

3.8

3.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

207

1640

1.28

2.85

4.6

5.6

0.82

0.87

1.30

197

1554

(3025159) Blasts/Leukocytes in Blood

388

3289

1.20

2.85

4.5

4.7

0.50

0.40

0.09

111

854

(3039162) Centromere protein B Ab [Units/volume] in Serum

455

1.53

2.85

1.3

45.15

76.24

u/ml

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

212

1688

1.27

2.81

1.8

2.5

3.47

3.70

g/l

2.19

190

1546

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

212

1689

1.27

2.80

1.8

2.5

4.18

4.23

g/l

0.54

190

1546

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

194

1.81

2.79

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.65

2.79

1.1

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

231

1.74

2.79

1.8

1.5

72.93

81.40

umol/l

1.79

231

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.92

2.77

1.0

—

(3010503) CD19 cells [#/volume] in Blood

202

1.79

2.76

1.9

2.2

1889.06

272.20

e6/l

0.44

192

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

419

1.54

2.74

1.2

—

41.83

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

240

1.72

2.73

1.0

1.1

9.33

9.02

iu/ml

—

(3023410) Appearance of Cerebral spinal fluid

348

1.59

2.73

1.7

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

167

1.86

2.71

1.2

1.3

157.26

156.42

mmol/24h

0.03

167

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.01

2.69

1.1

1.2

1.58

1.76

umol/24h

0.42

(3024891) Influenza virus A+B Ag [Presence] in Specimen

115

846

1.37

2.68

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

203

1619

1.27

2.67

1.9

1.44

2.13

ug/l

0.63

171

1438

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

220

1773

1.26

2.65

4.5

5.4

1.57

1.58

0.03

211

1684

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

199

1585

1.27

2.65

1.8

2.6

2.85

2.93

g/l

0.54

176

1442

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.93

2.61

1.7

1.2

54.23

103.07

ng/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.93

2.61

1.0

1.1

—

(3016038) Potassium [Moles/volume] in Urine

282

1.64

2.60

1.2

1.1

33.54

35.38

mmol/l

0.25

245

(4198724) Urine methamphetamine measurement

2.26

2.60

1.1

1.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

259

1.67

2.60

1.2

1.3

1.12

1.36

u/ml

0.10

145

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.34

2.60

1.3

1.8

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

673

1.41

2.59

1.2

48.00

435.44

titre

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

401

1.53

2.58

1.6

1.7

—

(3002179) Metamyelocytes/Leukocytes in Blood

380

3246

1.19

2.58

4.3

0.70

0.00

127

992

(3021440) Promyelocytes/Leukocytes in Blood

380

3250

1.19

2.55

4.5

4.6

0.12

0.11

0.02

112

892

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

7.15

2.55

1.0

1.1

0.21

0.22

g/l

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

5.46

2.54

1.0

0.01

0.26

u/ml

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

136

1037

1.32

2.53

1.7

2.0

2.60

9.70

iu/l

0.69

416

(3014271) Vancomycin [Susceptibility]

179

1.79

2.51

3.3

2.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

132

1006

1.32

2.47

1.3

1.2

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

188

1.76

2.44

1.2

0.52

0.56

ratio

0.47

108

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.90

2.41

1.1

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

138

1.89

2.40

1.1

128.83

393.73

ng/l

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

352

1.54

2.40

1.5

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

592

1.41

2.36

1.9

2.0

194.20

195.04

pmol/l

0.03

556

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.61

2.35

1.1

—

(3017181) Myelocytes/Leukocytes in Blood

394

3405

1.17

2.35

4.4

4.5

0.77

0.90

0.40

128

1042

(3003396) Base excess in Arterial blood by calculation

515

4544

1.15

2.35

5.9

7.6

0.90

1.06

mmol/l

0.39

421

3743

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.83

2.34

1.2

1.1

0.05

u/ml

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

535

1.43

2.33

1.2

4.11

4.71

u/ml

0.16

235

(3004716) Salmonella sp identified in Stool by Organism specific culture

197

1595

1.25

2.32

1.4

1.3

—

(3016502) Oxygen saturation in Arterial blood

464

4067

1.16

2.31

6.2

7.9

96.00

95.61

0.72

445

3928

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

112

1.97

2.30

1.5

0.51

0.40

ug/l

0.30

(3003888) Timothy IgE Ab [Units/volume] in Serum

495

1.44

2.30

1.1

3.69

3.84

u/ml

0.04

257

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

4.62

2.27

1.0

0.07

0.08

u/ml

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

4.62

2.27

1.0

0.04

2.31

u/ml

—

(40758558) Short blood count panel - Blood

1207

11235

1.11

2.27

6.6

6.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

480

1.45

2.26

1.1

0.53

1.12

u/ml

1.04

204

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

279

2349

1.20

2.25

6.9

9.1

24.37

24.33

mmol/l

0.07

269

2304

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

334

1.53

2.24

1.0

1.1

0.79

0.15

u/ml

0.46

114

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

675

1.37

2.24

1.2

—

242.86

—

(1761482) Bacteria [#/volume] in Urine by Culture

121

927

1.31

2.22

4.9

4.5

—

(3019230) Fractional oxyhemoglobin in Venous blood

109

823

1.33

2.21

1.9

2.5

59.11

61.32

0.50

109

818

(3032773) Endomysium IgG Ab [Titer] in Serum

320

1.54

2.18

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

101

756

1.34

2.17

1.9

45.53

42.89

nmol/l

0.44

725

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

108

1.95

2.15

2.0

1.9

1.93

0.80

u/ml

—

(3000991) Gas panel - Venous blood

381

3310

1.17

2.15

6.6

8.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

180

1457

1.25

2.14

1.8

2.6

10.29

10.30

g/l

0.01

154

1300

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

632

5691

1.13

2.14

1.6

1.5

—

(3019977) pH of Arterial blood

515

4576

1.14

2.13

6.0

7.6

7.43

7.42

2.21

280

2519

(3006462) Nitrate [Presence] in Urine

167

1.74

2.11

3.2

4.0

—

(4195642) Thrombophilia screening test

496

1.42

2.10

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.45

2.10

1.1

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

422

1.45

2.08

2.4

5.5

6.77

7.41

mmol/l

1.46

360

(3052851) Hemolysis interference index of Serum or Plasma

133

1044

1.28

2.06

3.6

3.5

1.61

1.98

index

0.43

523

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

139

1.80

2.04

2.0

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

376

1.47

2.00

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

263

1.56

2.00

1.4

1.3

1.43

1.14

promille

0.57

207

(3036670) Protein [Mass/volume] in Synovial fluid

104

1.93

2.00

1.1

1.3

43.92

38.68

g/l

1.01

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

186

1.67

1.97

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

186

1.67

1.97

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

186

1.67

1.97

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

186

1.67

1.97

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

179

1464

1.23

1.97

2.0

2.6

0.99

0.96

g/l

0.03

151

1258

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.08

1.96

1.1

0.12

1.92

u/ml

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

225

1.61

1.96

9.1

6.9

21.73

104.26

ug/l

0.54

140

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

432

3819

1.15

1.94

2.0

2.2

0.22

0.21

g/l

1.75

401

3572

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.97

1.93

1.5

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

511

4572

1.14

1.92

6.0

7.6

12.51

12.26

kpa

0.51

487

4393

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

511

4574

1.13

1.91

6.0

7.6

4.99

5.11

kpa

2.24

486

4396

(3035933) Granulocytes/Leukocytes in Blood

102

782

1.31

1.90

4.0

3.5

56.78

58.16

0.45

102

782

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

486

4340

1.14

1.89

7.0

7.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

136

1.77

1.87

1.4

1.5

88.59

327.81

nmol/24h

0.60

136

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

127

1006

1.27

1.86

1.3

1.4

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

425

1.42

1.84

1.4

1.5

59.83

59.20

0.04

261

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

708

1.32

1.83

1.4

2.0

0.90

0.84

nmol/l

0.49

593

(3029634) Reagin Ab [Titer] in Serum by VDRL

434

1.41

1.83

1.5

1.9

—

6.89

—

(1617658) Protocol used for examination of sentinel lymph nodes

318

1.48

1.83

1.0

1.1

—

(4211845) Urine protein measurement

183

1.64

1.81

3.3

3.8

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

160

1.69

1.81

1.1

—

8.05

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

160

1.69

1.81

1.1

1.5

30.58

29.85

umol/l

0.12

149

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

101

1.89

1.80

1.2

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

352

1.45

1.80

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

118

931

1.28

1.79

2.0

2.3

131.76

127.46

g/l

1.06

727

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

114

897

1.28

1.77

1.2

1.3

183.70

220.79

miu/ml

0.57

398

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

119

942

1.27

1.77

1.4

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

107

836

1.29

1.76

2.1

2.0

4837.09

5739.30

u/l

0.16

343

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

354

1.45

1.76

1.3

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

139

1.73

1.75

1.9

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

139

1.73

1.75

1.9

1.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

110

1.82

1.72

1.8

1.6

9.16

9.32

ug/l

0.05

110

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

103

1.85

1.71

1.2

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

103

1.85

1.71

1.4

1.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

398

1.41

1.71

1.1

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

394

3496

1.14

1.70

4.4

7.2

9.36

10.29

mmol/l

1.82

366

3353

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

543

1.35

1.70

1.2

2.04

3.50

u/ml

1.12

181

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.30

1.70

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

162

1336

1.22

1.69

1.7

1.6

0.24

0.33

mg/l

1.42

605

(3010144) Erythrocytes [#/volume] in Synovial fluid

349

1.44

1.68

1.3

1.4

255421.78

116581.98

e6/l

0.42

235

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

341

1.44

1.68

7.1

5.3

34.35

69.99

u/ml

0.82

104

(1002224) Polysomnography panel

174

1447

1.21

1.67

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

3.16

1.66

2.2

1.4

17.60

14.56

pmol/l

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

169

1403

1.21

1.65

2.8

3.6

35.80

62.68

mg/l

1.49

150

1199

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

188

1.60

1.65

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

309

1.46

1.65

1.2

—

(3004775) Volume in Urine collected for unspecified duration

277

1.49

1.63

2.5

2.2

663.43

637.44

0.07

182

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

310

1.46

1.63

1.6

1.5

24.45

19.94

u/ml

0.39

(46235355) HIV 1 and 2 tests - Meaningful Use set

578

5266

1.11

1.62

1.6

1.8

—

(3036603) Volume of Urine

287

1.47

1.59

1.5

1910.14

1879.48

0.10

281

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

524

1.34

1.59

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

329

1.43

1.58

1.6

1.5

—

(3047181) Lactate [Moles/volume] in Blood

139

1138

1.23

1.57

4.7

6.7

1.39

1.31

mmol/l

0.29

119

1005

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.82

1.57

1.2

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

465

1.36

1.57

1.6

1.5

23.21

26.31

ng/l

0.43

465

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

595

1.32

1.56

1.1

0.50

1.71

u/ml

2.85

331

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

139

1139

1.23

1.56

1.7

3.07

4.64

mg/l

1.36

118

860

(3007566) Smooth muscle Ab [Titer] in Serum

125

1013

1.24

1.55

1.2

80.00

99.44

titre

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

168

1404

1.21

1.55

2.8

3.6

44.27

92.85

mg/l

0.68

148

1201

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.28

1.55

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.93

1.54

1.3

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

153

1.64

1.53

1.0

0.59

1.84

u/ml

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

502

1.34

1.52

1.2

1.1

122.84

118.09

0.58

451

(3014133) Dog dander IgE Ab [Units/volume] in Serum

391

1.39

1.51

1.1

3.35

2.30

u/ml

0.22

187

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

138

1.67

1.51

1.1

1.2

—

(4268621) Lupus anticoagulant assay

383

1.39

1.51

2.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

106

847

1.26

1.50

2.4

3.3

228.47

831.35

u/ml

1.11

100

778

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

131

1.68

1.49

2.9

2.3

46.39

52.56

umol/l

0.48

114

(3020874) Milk IgE Ab [Units/volume] in Serum

162

1.61

1.49

1.0

0.49

0.95

u/ml

0.47

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

259

1.47

1.48

1.5

1.4

27.14

72.63

titre

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

147

1.64

1.47

1.0

5.3

83.07

61.32

mg/l

0.90

107

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

143

1185

1.21

1.46

2.1

2.5

0.00

g/l

-0.00

124

1041

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.84

1.45

1.1

—

(3016750) Collection duration of Urine

203

1.53

1.45

2.2

2.1

488.00

497.71

min

0.20

152

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.50

1.45

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

302

1.43

1.44

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

457

1.34

1.41

1.1

0.94

1.13

u/ml

0.22

233

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

131

1081

1.22

1.40

2.1

2.0

96.56

92.86

1.40

126

1045

(3033099) Centromere Ab [Titer] in Serum

1.86

1.40

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1040

0.78

1.40

1.4

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

749

1.26

1.38

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

749

1.26

1.38

1.4

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

364

1.38

1.0

1.1

2.46

2.93

u/ml

0.19

157

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1005

0.78

1.38

1.1

1.49

1.56

g/l

1.55

1005

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

400

3611

1.12

1.35

1.7

1.8

1.49

0.06

348

3135

(21494755) Public health laboratory ask at order entry panel

208

2398

0.86

1.34

1.3

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

105

1.72

1.33

1.2

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

931

0.78

1.32

1.1

0.63

ratio

0.01

138

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

133

1108

1.21

1.31

2.1

2.6

0.00

g/l

-0.00

123

1040

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

168

1.55

1.31

1.5

1.7

39.77

39.82

g/l

0.01

168

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

258

1.44

1.31

1.3

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.50

1.30

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

326

1.38

1.29

1.3

1.2

112.40

106.78

pmol/l

0.39

326

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

1.76

1.28

1.4

1.3

64.90

34.61

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

584

5394

1.10

1.28

5.8

6.9

104.65

104.19

mmol/l

1.70

584

5389

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

668

1.26

1.28

1.1

1.2

55.96

108.76

u/ml

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.79

1.27

1.0

1.2

—

(3044927) Protein electrophoresis panel - Urine

405

1.34

1.26

1.1

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

130

1.62

1.26

1.0

0.11

0.26

u/ml

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

227

1.46

1.26

1.5

1.8

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

294

1.40

1.26

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

294

1.40

1.26

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

107

1.69

1.25

1.2

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.40

1.24

2.3

2.6

—

(3006270) Folate [Moles/volume] in Blood

295

1.39

1.24

1.2

1.1

343.55

366.47

nmol/l

0.27

247

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

121

1007

1.21

1.23

2.4

2.3

191.50

196.04

0.23

110

957

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

127

1062

1.20

1.22

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.97

1.22

1.1

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.63

1.21

3.2

5.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

505

1.29

1.20

1.2

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

145

1231

1.18

1.19

2.0

2.5

0.02

g/l

0.01

131

1108

(3002173) Hemoglobin [Mass/volume] in Arterial blood

415

3790

1.11

1.16

6.8

8.4

122.93

120.21

g/l

2.13

402

3704

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

282

1.39

1.16

1.3

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

110

1.64

1.15

1.6

1.3

99.18

118.33

nmol/l

0.41

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.73

1.15

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1038

9861

1.07

1.14

1.4

—

(44806420) Estimation of glomerular filtration rate

369

1.33

1.14

2.7

2.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.69

1.13

3.1

7.99

8.16

mg/l

0.04

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

379

1.32

1.12

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

125

1055

1.19

1.11

2.8

3.0

1.54

1.63

mg/l

0.65

115

946

(4133840) Spirometry

1.78

1.10

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.26

1.10

1.1

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

226

1.42

1.09

1.3

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

104

1.64

1.09

1.0

1.2

99.33

87.49

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

252

1.39

1.08

1.2

1.7

82.92

107.73

ng/l

1.87

252

(3002523) Influenza virus A Ag [Presence] in Specimen

505

1.27

1.08

1.2

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.93

1.06

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

105

1.62

1.06

1.0

1.4

107.17

84.96

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

288

1.36

1.04

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.27

1.03

1.8

1.5

230.20

317.77

umol/24h

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.27

1.03

1.2

1.1

—

0.11

—

(3019150) Specific gravity of Urine by Refractometry

894

8479

1.07

1.03

4.6

4.4

1.02

1.19

kg/l

0.50

609

5689

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

204

1.42

1.02

1.2

1.1

39.19

17.00

u/ml

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

298

1.35

1.02

1.2

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

324

1.33

1.02

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

324

1.33

1.02

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

324

1.33

1.02

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

163

1.48

1.01

1.1

1385.42

1541.51

miu/ml

0.44

163

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

595

5564

1.08

1.01

3.5

3.3

0.75

0.79

ug/l

0.50

424

3790

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

674

1.22

0.99

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

263

2369

1.12

0.98

1.5

1.7

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.18

0.98

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.63

0.97

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

433

1.27

0.96

1.0

1.1

2.60

3.41

eliau/ml

0.16

173

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

789

7476

1.07

0.94

5.0

4.7

23.03

21.90

1.34

431

3822

(21494814) CD8 cells/Lymphocytes in Specimen

133

1.51

0.94

1.6

2.0

30.15

31.14

0.07

133

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

117

1.54

0.93

2.4

2.8

11.70

10.29

kpa

1.25

117

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

117

1.54

0.93

2.4

2.8

4.66

4.96

kpa

0.41

117

(3018333) Ribosomal P Ab [Presence] in Serum

277

1.34

0.93

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

175

1.43

0.92

1.6

1.8

2.60

1.93

u/field

0.13

122

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

175

1.43

0.92

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.14

0.91

1.3

1.1

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

303

0.69

0.91

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

185

1.41

0.89

1.8

2.7

1266.50

1119.89

u/ml

0.08

185

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

758

1.19

0.87

1.1

1.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.61

0.87

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

298

1.31

0.87

1.7

2.1

4.52

1.52

u/field

0.80

158

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

622

1.21

0.86

1.1

1.2

353.84

281.27

u/ml

0.49

380

(3008295) Osmolality of Serum or Plasma

441

1.25

0.86

1.7

1.4

278.58

275.25

mosm/kgh2o

0.53

334

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

114

984

1.16

0.84

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.76

0.83

1.3

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

112

0.54

0.83

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

112

0.54

0.83

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

112

0.54

0.83

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

112

0.54

0.83

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

422

0.76

0.82

1.4

1.5

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

197

1.37

0.82

1.1

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.88

0.81

2.7

2.1

1.90

1.49

mg/l

—

(3000012) Reticulocyte production index

572

1.21

0.80

2.4

2.1

0.91

0.90

0.04

393

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

822

1.17

0.79

1.3

1.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

139

1.44

0.79

1.8

2.2

17.17

19.62

ug/l

0.38

126

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.79

0.0

1.4

—

22.58

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

244

2223

1.10

0.78

8.0

10.2

16.16

15.83

1.12

234

2147

(3005033) Fetal Nuchal fold Thickness US

418

0.76

0.78

1.4

1.5

1.35

1.29

0.33

292

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.53

0.78

1.3

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

384

1.25

0.78

4.7

3.7

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

0.52

0.78

2.2

1.4

28.70

24.63

g/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

391

3641

1.08

0.77

1.3

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

119

1040

1.15

0.76

2.2

2.4

3.64

3.63

g/l

0.01

109

984

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

256

0.70

0.75

1.3

—

(40762887) Creatinine [Moles/volume] in Blood

2.08

0.74

1.2

1.7

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.84

0.73

1.6

1.4

—

(37208534) Antinuclear antibody arbitrary concentration in serum

108

1.48

0.73

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

108

1.48

0.73

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

451

1.22

0.73

1.7

—

(40768446) Kidney Pathology biopsy report

135

0.59

0.73

1.1

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

1.50

0.72

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.00

0.72

1.4

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

434

0.78

0.71

1.5

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.75

0.71

1.1

2.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

462

1.22

0.71

5.6

5.4

340.78

355.79

umol/l

0.34

409

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

141

1258

1.13

0.68

2.7

3.4

1.68

3.92

ratio

1.68

740

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.56

0.68

1.0

1.2

457.63

63.55

mg/l

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.67

0.68

1.4

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.68

1.3

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

110

1.46

0.68

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

529

1.19

0.67

3.5

3.0

—

(3045142) Bone marrow Pathology biopsy report

456

1.21

0.67

1.2

1.3

—

(40768800) Prostate Pathology biopsy report

625

0.83

0.65

1.3

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.73

0.64

1.0

1.1

89.60

97.10

titre

—

(3023183) Ammonium ion [Moles/volume] in Plasma

795

1.15

0.62

2.4

2.7

36.19

34.93

umol/l

0.12

714

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

833

1.14

0.62

2.3

129.09

102.14

ug/min

0.27

498

(3045716) Anion gap in Serum or Plasma by calculation

413

0.80

0.61

2.7

3.0

10.70

10.68

mmol/l

0.01

408

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.67

0.61

2.8

1.8

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.67

0.61

1.4

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

235

1.28

0.61

1.2

78.08

81.24

u/l

0.09

201

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

200

1.30

0.60

5.8

4.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.60

0.0

11.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.60

0.0

10.1

—

134.20

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

1.1

—

(44790048) Parainfluenza type 2 nucleic acid detection

477

0.82

0.60

1.5

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

477

0.82

0.60

1.5

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

477

0.82

0.60

1.5

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

477

0.82

0.60

1.5

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1023

0.88

0.59

2.1

1.8

—

30.85

—

(3039000) Anion gap in Blood by calculation

782

1.14

0.57

5.5

8.0

11.47

11.20

mmol/l

0.29

703

(3018572) Chloride [Moles/volume] in Blood

782

1.14

0.57

5.5

8.0

105.04

105.03

mmol/l

0.01

703

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

286

0.77

0.56

2.4

1.7

3.35

3.96

ug/l

0.19

238

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

699

1.15

0.56

1.2

1.3

24.04

33.30

u/l

0.88

600

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

448

1.19

0.56

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.62

0.55

1.3

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

813

1.13

0.55

1.5

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

421

1.19

0.55

1.6

2.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

138

1250

1.11

0.55

1.5

1.4

—

(3044007) Cell count panel - Peritoneal fluid

124

0.64

0.54

2.1

1.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

492

4690

1.06

0.53

1.4

1.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.54

0.53

1.3

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

108

1.39

0.53

2.8

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

544

1.16

0.53

1.2

1.1

97.50

1206.57

iu/ml

—

111

(3006922) Hepatitis E virus Ab [Presence] in Serum

268

1.23

0.52

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

132

0.68

0.51

1.6

2.5

—

21090.33

—

(40758292) HTLV I+II Ab panel - Serum

1.41

0.51

1.1

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

281

0.78

0.51

1.1

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

379

1.19

0.51

4.0

3.5

11.76

12.34

index

0.18

199

(3025130) Human papilloma virus identified in Specimen

531

0.85

0.50

1.6

1.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

380

1.19

0.49

1.4

1.3

7.27

7.47

mmol/l

0.18

331

(3048879) Bone marrow aspiration report

101

1.39

0.49

3.0

1.7

—

2.00

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

418

1.17

0.48

1.2

54.10

58.88

u/l

0.46

370

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

278

0.79

0.47

1.4

1.7

—

(3016228) CD19 cells/cells in Blood

137

1.32

0.47

1.6

2.0

11.56

7.82

0.32

130

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

227

1.24

0.46

1.2

19.38

21.84

u/l

0.16

189

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

328

3108

1.06

0.46

1.9

2.0

3.53

3.40

ratio

1.05

248

2411

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.43

0.46

2.1

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

117

0.68

0.45

1.8

1.9

2.11

1.57

ratio

—

110

(3028717) Thiamine [Mass/volume] in Blood

1.40

0.45

1.0

1.3

72.86

65.90

ug/l

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

113

1028

1.10

0.44

1.1

1.3

—

(40768793) Breast Pathology biopsy report

114

1038

1.10

0.44

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

488

1.15

0.44

1.8

2.2

0.67

1.25

g/24h

2.02

287

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

241

0.79

0.43

1.9

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.41

0.43

1.3

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

212

1.23

0.42

2.0

1.4

1.34

1.15

nmol/l

0.38

156

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

304

1.19

0.42

1.1

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.52

0.41

2.4

4.5

—

(3019174) dRVVT (LA screen)

1.52

0.41

1.0

1.2

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.52

0.41

9.0

12.9

0.16

0.19

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.41

0.0

3.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

337

0.83

0.41

1.4

1.3

—

(3023419) Bacteria identified in Sputum by Culture

520

1.14

0.41

2.7

2.6

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.40

0.0

1.2

—

2.59

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.47

0.40

1.4

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.31

0.39

1.5

2.1

18.93

16.88

umol/l

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

104

0.67

0.39

1.3

1.4

16.67

31.88

nmol/l

—

(3020393) Adenovirus Ag [Presence] in Stool

1.43

0.39

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.43

0.39

1.0

—

11.64

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.43

0.39

1.0

2.7

0.40

0.74

u/field

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

106

0.66

0.39

1.7

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

204

0.78

0.39

2.2

2.7

39.57

42.06

—

109

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

160

1.25

0.38

1.2

1.5

111.32

204.35

pmol/l

0.90

160

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

239

2260

1.06

0.38

1.6

1.7

3.49

3.46

mmol/l

0.11

161

1576

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2828

28035

1.03

0.37

24.9

21.2

13.65

13.73

2.80

2805

27648

(3045788) Cell count panel - Pleural fluid

419

0.86

0.37

1.4

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

271

1.18

0.37

1.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

107

1.31

0.37

1.6

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.35

0.37

2.6

2.8

0.98

0.61

ug/l

—

(3051101) Glucose [Moles/volume] in Cord blood

1.39

0.36

3.8

6.3

8.30

8.42

mmol/l

—

(3052592) Norovirus Ag [Presence] in Stool

1.27

0.36

1.1

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

259

2462

1.06

0.35

1.3

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

208

1.20

0.35

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

208

1.20

0.35

1.5

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

458

0.87

0.34

1.5

1.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.36

0.34

1.3

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.34

0.34

1.4

1.3

1.20

1.17

mmol/l

0.75

(3002619) Bacteria identified in Specimen by Culture

1.32

0.33

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

109

1.29

0.33

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

893

1.09

0.33

1.6

1.5

111.03

199.58

pmol/l

1.94

874

(3047189) Immunofixation for 24 hour Urine

199

0.80

0.33

1.3

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

577

1.11

0.33

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

551

0.89

0.33

3.9

6.6

12.58

12.48

mg/l

0.05

516

(3003329) Lymphocytes/Leukocytes in Synovial fluid

322

1.15

0.32

1.5

1.4

27.26

31.03

0.27

190

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

137

1.24

0.32

1.2

1.1

165.49

177.39

iu/ml

0.05

137

(3008152) Bicarbonate [Moles/volume] in Arterial blood

256

2445

1.05

0.31

5.8

7.0

24.78

24.59

mmol/l

0.35

242

2342

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

697

1.09

0.29

1.8

1.7

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

315

3029

1.04

0.29

3.4

2.7

64.49

63.99

ml/min/173m2

0.09

140

1312

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

163

0.80

0.29

8.8

14.3

901.00

828.09

nmol/l

0.17

158

(3045683) HLA typing for celiac disease panel - Blood or Tissue

194

1.19

0.29

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

206

0.82

0.29

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

249

0.84

0.29

1.9

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

270

0.85

0.28

1.8

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

450

0.89

0.28

1.4

43869.23

71525.66

e6/l

0.60

245

(4281824) Cell count and differential, peritoneal fluid

439

0.89

0.28

1.0

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

501

0.90

0.27

1.4

1.5

0.99

0.97

ratio

0.08

309

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

501

0.90

0.27

1.4

1.5

1.32

1.20

ratio

0.30

310

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

501

0.90

0.27

1.4

1.5

1.23

1.16

ratio

0.25

309

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

118

0.76

0.27

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

104

1.25

0.26

1.1

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.70

0.26

1.2

2.8

—

(3043409) Potassium [Moles/volume] in Arterial blood

113

1061

1.07

0.26

3.6

4.1

3.81

3.87

mmol/l

0.73

113

1052

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.69

0.26

7.6

7.5

4.54

5.47

kpa

—

(3020891) Body temperature

178

1867

0.95

0.25

4.3

4.4

36.91

36.92

°c

0.01

178

1851

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

498

0.90

0.25

1.4

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

321

1.12

0.24

1.8

1.6

—

(40768441) Liver Pathology biopsy report

276

0.87

0.24

1.2

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

161

1.18

0.24

2.3

2.1

193.00

116.19

umol/l

0.48

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.32

0.23

1.2

1.5

—

(40765096) Chromosome analysis panel by Banding

136

0.81

0.23

1.0

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2772

27885

0.98

0.22

25.4

22.3

332.02

331.33

g/l

3.81

2765

27717

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

248

1.13

0.21

1.3

1.5

6.46

7.05

u/l

0.09

202

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

2.74

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

5.1

—

407.00

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

39.02

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.6

—

1.34

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

594

1.08

0.21

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

1.53

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

8.1

—

101.25

—

(3013862) HLA-DP [Type]

0.00

0.20

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.20

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.20

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.20

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.20

0.0

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

239

0.88

0.19

1.7

2.0

—

(3014007) Fractional oxyhemoglobin in Arterial blood

268

2599

1.03

0.19

7.9

9.2

94.39

93.92

0.60

268

2592

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

146

1.17

0.19

1.8

75.43

56.59

ug/l

0.29

141

(21491868) Cryoglobulin [Mass/volume] in Serum

137

1.17

0.18

1.2

1.3

—

0.24

g/l

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.13

0.18

1.2

1.4

—

0.78

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

134

1286

1.04

0.17

3.0

0.41

0.35

iu/ml

1.00

715

(3027456) Digoxin [Moles/volume] in Serum or Plasma

886

1.05

0.16

3.2

3.5

0.87

0.81

nmol/l

0.35

724

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

103

984

1.05

0.16

1.7

1.5

—

(3020491) Glucose [Moles/volume] in Blood

254

1.10

0.16

1.7

1.9

6.79

6.71

mmol/l

0.06

169

(3008536) Aspergillus sp Ab [Presence] in Serum

1.10

0.15

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.10

0.15

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

153

1477

1.04

0.15

2.2

3.5

126.94

3116.93

u/ml

0.95

126

1261

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

673

1.06

0.15

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

758

0.95

0.14

3.8

3.5

23.33

28.03

mg/l

0.66

519

(3001019) Free T4 and TSH panel - Serum or Plasma

147

1519

0.97

0.14

1.5

1.8

—

(3000034) Microalbumin [Mass/volume] in Urine

305

0.92

0.13

3.3

3.0

44.59

35.42

mg/l

0.12

224

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

541

0.94

0.13

1.4

1.5

59.58

61.34

ug/l

0.10

445

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

745

0.95

0.13

1.5

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

132

1.14

0.13

1.3

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

113

1.15

0.13

1.9

2.4

185.23

185.34

0.00

105

(3000919) Neutrophils/Leukocytes in Pleural fluid

117

0.85

0.13

1.3

1.5

16.92

22.90

—

107

(3034426) Prothrombin time (PT)

107

0.84

0.13

1.4

1.3

27.00

28.43

—

107

(3022689) Creatine [Moles/volume] in Urine

110

0.82

0.13

1.8

1.4

8.15

7.17

mmol/l

—

110

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

277

1.08

0.12

1.3

1.5

12.60

13.11

u/l

0.21

266

(3017704) Immunofixation for Urine

219

1.10

0.12

1.9

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

127

0.87

0.12

1.2

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

757

1.04

0.12

3.5

5.1

286.63

507.05

iu/ml

—

111

(3023199) Leukocytes [#/volume] in Pleural fluid

507

0.95

0.11

1.4

1.5

3018.85

3481.86

e6/l

0.09

352

(3017569) Oxygen content in Arterial blood

230

1.09

0.11

2.0

2.4

15.74

16.23

0.29

230

(3001893) Eosinophils/Leukocytes in Pleural fluid

126

0.87

0.11

1.2

1.5

7.56

2.57

0.64

107

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

494

1.05

0.11

1.7

1.6

—

(3024263) Appearance of Synovial fluid

188

0.90

0.11

1.9

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

691

1.04

0.10

1.2

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

301

0.93

0.10

5.5

2.8

20.86

28.67

mg/l

0.75

215

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

265

2601

1.02

0.10

7.8

9.1

1.22

1.31

0.85

265

2587

(3035880) pH of Pleural fluid

239

0.92

0.10

1.4

1.3

7.31

7.41

2.14

166

(3020650) Glucose [Presence] in Urine

125

1.12

0.10

2.0

0.00

0.05

estimate

0.80

125

(40768795) Lymph node Pathology biopsy report

398

1.06

0.10

1.3

1.2

—

(3014891) Appearance of Pleural fluid

1.06

0.09

1.8

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.04

0.09

2.6

3.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.04

0.09

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

462

0.95

0.09

1.5

0.32

0.35

nmol/l

0.10

348

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1.04

0.08

1.3

1.7

—

73.67

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.86

0.07

1.0

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.80

0.07

1.0

26.83

40.91

iu/ml

—

(40757373) Influenza virus identified in Isolate

1.07

0.07

1.1

1.5

—

(4035726) Immunohistochemistry procedure

350

3459

1.01

0.07

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

758

1.03

0.07

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.87

0.06

1.1

—

(21494434) Karyotype in Bone marrow

344

1.05

0.06

1.1

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

618

0.97

0.06

1.5

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

633

1.03

0.05

1.3

1.4

—

19.67

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

927

0.98

0.04

1.5

1.6

1113.62

1035.58

mu/l

0.31

760

(3012441) Differential panel - Pleural fluid

427

1.03

0.04

1.3

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

229

1.05

0.04

1.7

2.1

7.28

8.53

mmol/l

1.38

229

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

594

0.98

0.04

1.2

1.4

172.40

157.10

au/ml

0.38

177

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

402

0.97

0.04

2.0

1.7

—

(40768806) Pleura Pathology biopsy report

428

1.03

0.03

1.4

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

210

1.05

0.03

1.1

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

501

0.98

0.03

1.7

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

540

0.98

0.02

1.4

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

167

0.96

0.01

2.5

3.4

0.94

1.18

0.28

167

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

227

0.97

0.01

1.2

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

283

1.02

0.01

1.0

677.14

727.89

ng/l

0.25

184

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

283

1.02

0.01

1.0

371.83

317.67

ng/l

0.41

188

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

124

1.05

0.00

1.2

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

126

0.95

0.00

1.2

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

334

1.02

0.00

1.5

1.8

6.56

4.37

mg/l

0.39

325

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

486

0.99

0.00

1.1

1.37

1.53

g/l

3.11

441

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

866

0.99

0.00

1.5

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

138

1.01

0.00

2.1

2.6

0.64

0.61

mmol/l

1.00

138

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

302

0.99

0.00

1.3

13.73

11.54

u/l

0.29

278

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

338

1.01

0.00

1.3

1.5

49.91

58.34

ug/l

0.82

338

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

285

1.02

0.00

1.0

53.12

42.34

ng/l

0.51

186

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

139

1.01

0.00

1.1

1.2

8.36

10.24

mm/h

0.38

139

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

189

1.01

0.00

1.8

1.7

2.88

7.02

nmol/l

0.86

158

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

479

1.00

0.00

1.1

—

(3037756) Immunofixation for Serum or Plasma

859

1.00

0.00

1.5

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

614

0.99

0.00

1.4

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

144

0.97

0.00

1.3

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

102

1023

1.00

0.00

1.8

1.6

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

1.30

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.6

—

46.66

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.97

-0.00

1.0

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

5.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.92

-0.00

1.6

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

0.91

-0.00

7.8

7.5

9.24

10.47

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

1.92

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

2.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

2.0

—

4.37

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.89

-0.00

2.6

2.4

2.43

437.33

ug/l

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.02

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.1

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.0

—

1.00

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.2

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3018133) Calcium [Moles/volume] in Urine

0.96

-0.00

1.0

1.5

2.33

2.61

mmol/l

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.2

—

6.88

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.98

-0.00

1.8

1.5

0.66

0.46

e9/l

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

4.4

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.2

—

4.40

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_PERIPHVERTIGO and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_PERIPHVERTIGO	0.894 [0.82, 0.97]	0.011
Birth year	0.99 [0.98, 1.0]	0.021

During the follow-up period (1.1.1998 — 31.12.2019), 2271 out of 12753 females with H8_PERIPHVERTIGO died.

Males

Parameter	HR [95% CI]	p-value
H8_PERIPHVERTIGO	0.862 [0.78, 0.95]	0.003
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 1428 out of 7125 males with H8_PERIPHVERTIGO died.

Mortality risk

Mortality risk for people of age

years, who have H8_PERIPHVERTIGO.

N-year risk	Females	Males
1	0.056%	0.167%
5	0.442%	1.004%
10	1.156%	2.399%
15	2.051%	4.41%
20	3.659%	7.397%

Relationships between endpoints

↥

Index endpoint: H8_PERIPHVERTIGO – Other peripheral vertigo

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other peripheral vertigo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints